Your search resulted in multiple matches. Please select a position:

Gencode Genes

FUS (ENST00000254108.11) at chr16:31180110-31194871 - Homo sapiens FUS RNA binding protein (FUS), transcript variant 2, non-coding RNA. (from RefSeq NR_028388)
FUS (ENST00000570090.1) at chr16:31185080-31187245 - FUS RNA binding protein (from HGNC FUS)
FUS (ENST00000569760.5) at chr16:31190216-31191605 - FUS RNA binding protein (from HGNC FUS)
FUS (ENST00000568901.2) at chr16:31188152-31190120 - FUS RNA binding protein (from HGNC FUS)
FUS (ENST00000568685.1) at chr16:31180151-31191575 - The sequence shown here is derived from an Ensembl  automatic analysis pipeline and should be considered as  preliminary data. (from UniProt H3BPE7)
FUS (ENST00000566605.5) at chr16:31180138-31191602 - The sequence shown here is derived from an Ensembl  automatic analysis pipeline and should be considered as  preliminary data. (from UniProt H3BNZ4)
FUS (ENST00000564766.1) at chr16:31188467-31189695 - FUS RNA binding protein (from HGNC FUS)
FUS (ENST00000487974.1) at chr16:31183550-31184398 - FUS RNA binding protein (from HGNC FUS)
FUS (ENST00000487509.6) at chr16:31180150-31191602 - FUS RNA binding protein (from HGNC FUS)
FUS (ENST00000487045.6) at chr16:31180139-31183350 - FUS RNA binding protein (from HGNC FUS)
FUS (ENST00000483853.1) at chr16:31190373-31191558 - FUS RNA binding protein (from HGNC FUS)
FUS (ENST00000474990.5) at chr16:31185499-31191102 - FUS RNA binding protein (from HGNC FUS)
FUS (ENST00000380244.7) at chr16:31180139-31191602 - Homo sapiens FUS RNA binding protein (FUS), transcript variant 3, mRNA. (from RefSeq NM_001170634)
NAA80 (ENST00000452674.1) at chr3:50297436-50298889 - Homo sapiens cDNA, FLJ94421, Homo sapiens putative tumor suppressor (FUS2), mRNA. (from mRNA AK313803)
TUSC2 (ENST00000232496.5) at chr3:50324909-50328223 - Homo sapiens tumor suppressor 2, mitochondrial calcium regulator (TUSC2), mRNA. (from RefSeq NM_007275)
NAA80 (ENST00000354862.4) at chr3:50296402-50299416 - Homo sapiens N(alpha)-acetyltransferase 80, NatH catalytic subunit (NAA80), transcript variant 1, mRNA. (from RefSeq NM_012191)
NAA80 (ENST00000443094.2) at chr3:50296418-50299421 - Homo sapiens N(alpha)-acetyltransferase 80, NatH catalytic subunit (NAA80), transcript variant 2, mRNA. (from RefSeq NM_001200016)
NAA80 (ENST00000417393.1) at chr3:50296404-50298859 - Homo sapiens N(alpha)-acetyltransferase 80, NatH catalytic subunit (NAA80), transcript variant 3, mRNA. (from RefSeq NM_001200018)
NAA80 (ENST00000443842.1) at chr3:50296452-50299400 - Seems to be involved in N-acetylation. Acts on peptides  with a N-terminal Met followed by Asp/Glu/Asn. May act as a tumor  suppressor. (from UniProt Q93015)
GPS1 (ENST00000624957.3) at chr17:82051893-82057440 - Homo sapiens G protein pathway suppressor 1 (GPS1), transcript variant 9, mRNA. (from RefSeq NM_001330541)
GPS1 (ENST00000623691.3) at chr17:82051897-82057470 - Homo sapiens G protein pathway suppressor 1 (GPS1), transcript variant 8, mRNA. (from RefSeq NM_001330539)
GPS1 (ENST00000320548.8) at chr17:82051875-82057470 - Homo sapiens G protein pathway suppressor 1 (GPS1), transcript variant 7, mRNA. (from RefSeq NM_001321093)
GPS1 (ENST00000392358.6) at chr17:82051958-82057470 - Homo sapiens G protein pathway suppressor 1 (GPS1), transcript variant 1, mRNA. (from RefSeq NM_212492)
GPS1 (ENST00000578552.5) at chr17:82051865-82057470 - Homo sapiens G protein pathway suppressor 1 (GPS1), transcript variant 6, mRNA. (from RefSeq NM_001321092)
GPS1 (ENST00000306823.10) at chr17:82051909-82057470 - Homo sapiens G protein pathway suppressor 1 (GPS1), transcript variant 2, mRNA. (from RefSeq NM_004127)
DDIT3 (ENST00000346473.7) at chr12:57516593-57520517 - Homo sapiens DNA damage inducible transcript 3 (DDIT3), transcript variant 5, mRNA. (from RefSeq NM_004083)
DDIT3 (ENST00000551116.5) at chr12:57516589-57520517 - Homo sapiens DNA damage inducible transcript 3 (DDIT3), transcript variant 4, mRNA. (from RefSeq NM_001195056)
TDRD3 (ENST00000535286.5) at chr13:60397293-60573878 - Homo sapiens tudor domain containing 3 (TDRD3), transcript variant 1, mRNA. (from RefSeq NM_001146070)
TDRD3 (ENST00000196169.7) at chr13:60396457-60573878 - Homo sapiens tudor domain containing 3 (TDRD3), transcript variant 2, mRNA. (from RefSeq NM_030794)
ATF1 (ENST00000262053.8) at chr12:50764101-50821162 - Homo sapiens activating transcription factor 1 (ATF1), mRNA. (from RefSeq NM_005171)
ERG (ENST00000398910.5) at chr21:38380027-38661694 - Homo sapiens ETS transcription factor ERG (ERG), transcript variant 8, mRNA. (from RefSeq NM_001291391)
ERG (ENST00000398905.5) at chr21:38380027-38498442 - Homo sapiens ETS transcription factor ERG (ERG), transcript variant 10, mRNA. (from RefSeq NM_001331025)
ERG (ENST00000453032.6) at chr21:38383126-38498476 - Homo sapiens ETS transcription factor ERG (ERG), transcript variant 4, mRNA. (from RefSeq NM_001136155)
ERG (ENST00000485493.1) at chr21:38470775-38661694 - Homo sapiens ETS transcription factor ERG (ERG), transcript variant 9, non-coding RNA. (from RefSeq NR_111949)
SARNP (ENST00000546604.5) at chr12:55752463-55817724 - Homo sapiens SAP domain containing ribonucleoprotein (SARNP), transcript variant 2, non-coding RNA. (from RefSeq NR_026723)
ERG (ENST00000417133.6) at chr21:38380027-38661694 - Homo sapiens ETS transcription factor ERG (ERG), transcript variant 7, mRNA. (from RefSeq NM_001243432)
ERG (ENST00000442448.5) at chr21:38380030-38661780 - Homo sapiens ETS transcription factor ERG (ERG), transcript variant 2, mRNA. (from RefSeq NM_004449)
ERG (ENST00000398919.6) at chr21:38383291-38660667 - Homo sapiens ETS transcription factor ERG (ERG), transcript variant 5, mRNA. (from RefSeq NM_001243428)
ERG (ENST00000398897.5) at chr21:38380027-38584900 - Homo sapiens ETS transcription factor ERG (ERG), transcript variant 6, mRNA. (from RefSeq NM_001243429)
SARNP (ENST00000336133.8) at chr12:55757270-55817724 - Homo sapiens SAP domain containing ribonucleoprotein (SARNP), transcript variant 1, mRNA. (from RefSeq NM_033082)
ERG (ENST00000288319.12) at chr21:38380036-38498477 - Homo sapiens ETS transcription factor ERG (ERG), transcript variant 1, mRNA. (from RefSeq NM_182918)
TDRD3 (ENST00000648252.1) at chr13:60397831-60573864 - Scaffolding protein that specifically recognizes and  binds dimethylarginine-containing proteins. In nucleus, acts as a  coactivator: recognizes and binds asymmetric dimethylation on the  core histone tails associated with transcriptional activation  (H3R17me2a and H4R3me2a) and recruits proteins at these arginine-  methylated loci. In cytoplasm, may play a role in the assembly  and/or disassembly of mRNA stress granules and in the regulation  of translation of target mRNAs by binding Arg/Gly-rich motifs  (GAR) in dimethylarginine-containing proteins. (from UniProt Q9H7E2)
TDRD3 (ENST00000377881.6) at chr13:60397334-60573872 - Scaffolding protein that specifically recognizes and  binds dimethylarginine-containing proteins. In nucleus, acts as a  coactivator: recognizes and binds asymmetric dimethylation on the  core histone tails associated with transcriptional activation  (H3R17me2a and H4R3me2a) and recruits proteins at these arginine-  methylated loci. In cytoplasm, may play a role in the assembly  and/or disassembly of mRNA stress granules and in the regulation  of translation of target mRNAs by binding Arg/Gly-rich motifs  (GAR) in dimethylarginine-containing proteins. (from UniProt Q9H7E2)
SF1 (ENST00000334944.9) at chr11:64764606-64778786 - Homo sapiens splicing factor 1 (SF1), transcript variant 2, mRNA. (from RefSeq NM_201995)
SF1 (ENST00000433274.6) at chr11:64765652-64777760 - Homo sapiens splicing factor 1 (SF1), transcript variant 5, mRNA. (from RefSeq NM_001178031)
SF1 (ENST00000377394.7) at chr11:64764606-64778747 - Homo sapiens splicing factor 1 (SF1), transcript variant 4, mRNA. (from RefSeq NM_201997)
SF1 (ENST00000377390.7) at chr11:64764606-64778730 - Homo sapiens splicing factor 1 (SF1), transcript variant 1, mRNA. (from RefSeq NM_004630)
SF1 (ENST00000377387.5) at chr11:64764606-64778469 - Homo sapiens splicing factor 1 (SF1), transcript variant 6, mRNA. (from RefSeq NM_001178030)
SF1 (ENST00000227503.13) at chr11:64764606-64778747 - Homo sapiens splicing factor 1 (SF1), transcript variant 3, mRNA. (from RefSeq NM_201998)
TDRD3 (ENST00000377894.6) at chr13:60396988-60573877 - Scaffolding protein that specifically recognizes and  binds dimethylarginine-containing proteins. In nucleus, acts as a  coactivator: recognizes and binds asymmetric dimethylation on the  core histone tails associated with transcriptional activation  (H3R17me2a and H4R3me2a) and recruits proteins at these arginine-  methylated loci. In cytoplasm, may play a role in the assembly  and/or disassembly of mRNA stress granules and in the regulation  of translation of target mRNAs by binding Arg/Gly-rich motifs  (GAR) in dimethylarginine-containing proteins. (from UniProt Q9H7E2)
TDRD3 (ENST00000621840.4) at chr13:60434047-60573870 - Scaffolding protein that specifically recognizes and  binds dimethylarginine-containing proteins. In nucleus, acts as a  coactivator: recognizes and binds asymmetric dimethylation on the  core histone tails associated with transcriptional activation  (H3R17me2a and H4R3me2a) and recruits proteins at these arginine-  methylated loci. In cytoplasm, may play a role in the assembly  and/or disassembly of mRNA stress granules and in the regulation  of translation of target mRNAs by binding Arg/Gly-rich motifs  (GAR) in dimethylarginine-containing proteins. (from UniProt Q9H7E2)
ILF3 (ENST00000588657.5) at chr19:10670606-10689312 - May facilitate double-stranded RNA-regulated gene  expression at the level of post-transcription. Can act as a  translation inhibitory protein which binds to coding sequences of  acid beta-glucosidase (GCase) and other mRNAs and functions at the  initiation phase of GCase mRNA translation, probably by inhibiting  its binding to polysomes. Can regulate protein arginine N-  methyltransferase 1 activity. May regulate transcription of the  IL2 gene during T-cell activation. Can promote the formation of  stable DNA-dependent protein kinase holoenzyme complexes on DNA. (from UniProt Q12906)
ILF3 (ENST00000592763.5) at chr19:10670606-10685765 - May facilitate double-stranded RNA-regulated gene  expression at the level of post-transcription. Can act as a  translation inhibitory protein which binds to coding sequences of  acid beta-glucosidase (GCase) and other mRNAs and functions at the  initiation phase of GCase mRNA translation, probably by inhibiting  its binding to polysomes. Can regulate protein arginine N-  methyltransferase 1 activity. May regulate transcription of the  IL2 gene during T-cell activation. Can promote the formation of  stable DNA-dependent protein kinase holoenzyme complexes on DNA. (from UniProt Q12906)
ERG (ENST00000398911.5) at chr21:38380027-38584945 - Transcriptional regulator. May participate in  transcriptional regulation through the recruitment of SETDB1  histone methyltransferase and subsequent modification of local  chromatin structure. (from UniProt P11308)
ILF3 (ENST00000590261.5) at chr19:10670606-10689846 - Homo sapiens interleukin enhancer binding factor 3 (ILF3), transcript variant 1, mRNA. (from RefSeq NM_012218)
ILF3 (ENST00000250241.12) at chr19:10670537-10685765 - Homo sapiens interleukin enhancer binding factor 3 (ILF3), transcript variant 3, mRNA. (from RefSeq NM_153464)
ILF3 (ENST00000589998.5) at chr19:10654361-10684761 - Homo sapiens interleukin enhancer binding factor 3 (ILF3), transcript variant 2, mRNA. (from RefSeq NM_004516)
ILF3 (ENST00000407004.7) at chr19:10654328-10685765 - Homo sapiens interleukin enhancer binding factor 3 (ILF3), transcript variant 5, mRNA. (from RefSeq NM_001137673)
ILF3 (ENST00000449870.5) at chr19:10654261-10692417 - Homo sapiens interleukin enhancer binding factor 3 (ILF3), transcript variant 4, mRNA. (from RefSeq NM_017620)
CREB3L2 (ENST00000456390.5) at chr7:137884267-138002067 - Transcriptional activator which is processed and  activated during endoplasmic reticulum stress late phase. Binds to  the cAMP response element (CRE) and activates transcription  through CRE. Regulates the transcription of unfolded protein  response target genes, preventing accumulation of unfolded  proteins in damaged neurons. Also regulates the expression of  SEC23A, accelerating protein trafficking from the ER to the Golgi  thereby playing a key role in chondrocyte differentiation and  formation of epiphyseal cartilage (By similarity). (from UniProt Q70SY1)
TP63 (ENST00000456148.1) at chr3:189789801-189894502 - Acts as a sequence specific DNA binding transcriptional  activator or repressor. The isoforms contain a varying set of  transactivation and auto-regulating transactivation inhibiting  domains thus showing an isoform specific activity. Isoform 2  activates RIPK4 transcription. May be required in conjunction with  TP73/p73 for initiation of p53/TP53 dependent apoptosis in  response to genotoxic insults and the presence of activated  oncogenes. Involved in Notch signaling by probably inducing JAG1  and JAG2. Plays a role in the regulation of epithelial  morphogenesis. The ratio of DeltaN-type and TA*-type isoforms may  govern the maintenance of epithelial stem cell compartments and  regulate the initiation of epithelial stratification from the  undifferentiated embryonal ectoderm. Required for limb formation  from the apical ectodermal ridge. Activates transcription of the  p21 promoter. (from UniProt Q9H3D4)
TP63 (ENST00000449992.5) at chr3:189789801-189894502 - Homo sapiens tumor protein p63 (TP63), transcript variant 9, mRNA. (from RefSeq NM_001329146)
TP63 (ENST00000440651.6) at chr3:189631516-189894502 - Homo sapiens tumor protein p63 (TP63), transcript variant 10, mRNA. (from RefSeq NM_001329148)
TP63 (ENST00000392461.7) at chr3:189789801-189894231 - Homo sapiens tumor protein p63 (TP63), transcript variant 12, mRNA. (from RefSeq NM_001329150)
TP63 (ENST00000320472.9) at chr3:189631488-189894702 - Homo sapiens tumor protein p63 (TP63), transcript variant 7, mRNA. (from RefSeq NM_001329144)
TP63 (ENST00000264731.8) at chr3:189631389-189897276 - Homo sapiens tumor protein p63 (TP63), transcript variant 1, mRNA. (from RefSeq NM_003722)
TP63 (ENST00000437221.5) at chr3:189789801-189881496 - Homo sapiens tumor protein p63 (TP63), transcript variant 6, mRNA. (from RefSeq NM_001114982)
TP63 (ENST00000418709.6) at chr3:189631488-189881496 - Homo sapiens tumor protein p63 (TP63), transcript variant 3, mRNA. (from RefSeq NM_001114979)
TP63 (ENST00000392463.6) at chr3:189789801-189894221 - Homo sapiens tumor protein p63 (TP63), transcript variant 5, mRNA. (from RefSeq NM_001114981)
TP63 (ENST00000392460.7) at chr3:189631516-189894221 - Homo sapiens tumor protein p63 (TP63), transcript variant 2, mRNA. (from RefSeq NM_001114978)
TP63 (ENST00000354600.9) at chr3:189789660-189897268 - Homo sapiens tumor protein p63 (TP63), transcript variant 4, mRNA. (from RefSeq NM_001114980)
OTUB1 (ENST00000538426.5) at chr11:63986413-63998415 - Homo sapiens OTU deubiquitinase, ubiquitin aldehyde binding 1 (OTUB1), transcript variant 1, mRNA. (from RefSeq NM_017670)
OTUB1 (ENST00000428192.6) at chr11:63986012-63997703 - Hydrolase that can specifically remove 'Lys-48'-linked  conjugated ubiquitin from proteins and plays an important  regulatory role at the level of protein turnover by preventing  degradation. Regulator of T-cell anergy, a phenomenon that occurs  when T-cells are rendered unresponsive to antigen rechallenge and  no longer respond to their cognate antigen. Acts via its  interaction with RNF128/GRAIL, a crucial inductor of CD4 T-cell  anergy. Isoform 1 destabilizes RNF128, leading to prevent anergy.  In contrast, isoform 2 stabilizes RNF128 and promotes anergy.  Surprisingly, it regulates RNF128-mediated ubiquitination, but  does not deubiquitinate polyubiquitinated RNF128. Deubiquitinates  estrogen receptor alpha (ESR1). Mediates deubiquitination of 'Lys-  48'-linked polyubiquitin chains, but not 'Lys-63'-linked  polyubiquitin chains. Not able to cleave di-ubiquitin. Also  capable of removing NEDD8 from NEDD8 conjugates, but with a much  lower preference compared to 'Lys-48'-linked ubiquitin. (from UniProt Q96FW1)
DDIT3 (ENST00000552740.5) at chr12:57516809-57520511 - Multifunctional transcription factor in ER stress  response. Plays an essential role in the response to a wide  variety of cell stresses and induces cell cycle arrest and  apoptosis in response to ER stress. Plays a dual role both as an  inhibitor of CCAAT/enhancer-binding protein (C/EBP) function and  as an activator of other genes. Acts as a dominant-negative  regulator of C/EBP-induced transcription: dimerizes with members  of the C/EBP family, impairs their association with C/EBP binding  sites in the promoter regions, and inhibits the expression of  C/EBP regulated genes. Positively regulates the transcription of  TRIB3, IL6, IL8, IL23, TNFRSF10B/DR5, PPP1R15A/GADD34, BBC3/PUMA,  BCL2L11/BIM and ERO1L. Negatively regulates; expression of BCL2  and MYOD1, ATF4-dependent transcriptional activation of asparagine  synthetase (ASNS), CEBPA-dependent transcriptional activation of  hepcidin (HAMP) and CEBPB-mediated expression of peroxisome  proliferator-activated receptor gamma (PPARG). Inhibits the  canonical Wnt signaling pathway by binding to TCF7L2/TCF4,  impairing its DNA-binding properties and repressing its  transcriptional activity. Plays a regulatory role in the  inflammatory response through the induction of caspase-11  (CASP4/CASP11) which induces the activation of caspase-1 (CASP1)  and both these caspases increase the activation of pro-IL1B to  mature IL1B which is involved in the inflammatory response. (from UniProt P35638)
TBC1D25 (ENST00000481090.6) at chrX:48539737-48559886 - Acts as a GTPase-activating protein specific for RAB33B.  Involved in the regulation of autophagosome maturation, the  process in which autophagosomes fuse with endosomes and lysosomes. (from UniProt Q3MII6)
FUBP3 (ENST00000319725.10) at chr9:130579577-130638352 - Homo sapiens far upstream element binding protein 3 (FUBP3), mRNA. (from RefSeq NM_003934)
FUBP1 (ENST00000294623.8) at chr1:77946482-77979087 - Homo sapiens far upstream element binding protein 1 (FUBP1), transcript variant 5, non-coding RNA. (from RefSeq NR_146540)
FUBP1 (ENST00000370768.6) at chr1:77948405-77979086 - Homo sapiens far upstream element binding protein 1 (FUBP1), transcript variant 2, mRNA. (from RefSeq NM_003902)
PUF60 (ENST00000527197.5) at chr8:143816520-143829320 - Homo sapiens poly(U) binding splicing factor 60 (PUF60), transcript variant 5, mRNA. (from RefSeq NM_001271097)
PUF60 (ENST00000456095.6) at chr8:143816377-143829303 - Homo sapiens poly(U) binding splicing factor 60 (PUF60), transcript variant 7, mRNA. (from RefSeq NM_001271099)
PUF60 (ENST00000453551.6) at chr8:143816377-143829026 - Homo sapiens poly(U) binding splicing factor 60 (PUF60), transcript variant 3, mRNA. (from RefSeq NM_001136033)
PUF60 (ENST00000349157.10) at chr8:143816377-143829352 - Homo sapiens poly(U) binding splicing factor 60 (PUF60), transcript variant 2, mRNA. (from RefSeq NM_014281)
PUF60 (ENST00000313352.11) at chr8:143816377-143829039 - Homo sapiens poly(U) binding splicing factor 60 (PUF60), transcript variant 8, mRNA. (from RefSeq NM_001271100)
PUF60 (ENST00000526683.6) at chr8:143816344-143829315 - Homo sapiens poly(U) binding splicing factor 60 (PUF60), transcript variant 1, mRNA. (from RefSeq NM_078480)
DCLRE1B (ENST00000650450.2) at chr1:113905326-113914086 - Homo sapiens DNA cross-link repair 1B (DCLRE1B), transcript variant 1, mRNA. (from RefSeq NM_022836)
STIL (ENST00000396221.6) at chr1:47250622-47313135 - Homo sapiens STIL centriolar assembly protein (STIL), transcript variant 4, mRNA. (from RefSeq NM_001282937)
STIL (ENST00000337817.9) at chr1:47250139-47314147 - Homo sapiens STIL centriolar assembly protein (STIL), transcript variant 6, mRNA. (from RefSeq NM_001282939)
STIL (ENST00000360380.7) at chr1:47250139-47314147 - Homo sapiens STIL centriolar assembly protein (STIL), transcript variant 2, mRNA. (from RefSeq NM_003035)
STIL (ENST00000371877.7) at chr1:47250142-47314140 - Homo sapiens STIL centriolar assembly protein (STIL), transcript variant 1, mRNA. (from RefSeq NM_001048166)
STAT5B (ENST00000293328.7) at chr17:42199168-42276406 - Homo sapiens signal transducer and activator of transcription 5B (STAT5B), mRNA. (from RefSeq NM_012448)
HLA-DQB1 (ENST00000424806.1) at chr6_GL000253v2_alt:4076917-4086211 - Binds peptides derived from antigens that access the  endocytic route of antigen presenting cells (APC) and presents  them on the cell surface for recognition by the CD4 T-cells. The  peptide binding cleft accommodates peptides of 10-30 residues. The  peptides presented by MHC class II molecules are generated mostly  by degradation of proteins that access the endocytic route, where  they are processed by lysosomal proteases and other hydrolases.  Exogenous antigens that have been endocytosed by the APC are thus  readily available for presentation via MHC II molecules, and for  this reason this antigen presentation pathway is usually referred  to as exogenous. As membrane proteins on their way to degradation  in lysosomes as part of their normal turn-over are also contained  in the endosomal/lysosomal compartments, exogenous antigens must  compete with those derived from endogenous components. Autophagy  is also a source of endogenous peptides, autophagosomes  constitutively fuse with MHC class II loading compartments. In  addition to APCs, other cells of the gastrointestinal tract, such  as epithelial cells, express MHC class II molecules and CD74 and  act as APCs, which is an unusual trait of the GI tract. To produce  a MHC class II molecule that presents an antigen, three MHC class  II molecules (heterodimers of an alpha and a beta chain) associate  with a CD74 trimer in the ER to form a heterononamer. Soon after  the entry of this complex into the endosomal/lysosomal system  where antigen processing occurs, CD74 undergoes a sequential  degradation by various proteases, including CTSS and CTSL, leaving  a small fragment termed CLIP (class-II-associated invariant chain  peptide). The removal of CLIP is facilitated by HLA-DM via direct  binding to the alpha-beta-CLIP complex so that CLIP is released.  HLA-DM stabilizes MHC class II molecules until primary high  affinity antigenic peptides are bound. The MHC II molecule bound  to a peptide is then transported to the cell membrane surface. In  B-cells, the interaction between HLA-DM and MHC class II molecules  is regulated by HLA-DO. Primary dendritic cells (DCs) also to  express HLA-DO. Lysosomal miroenvironment has been implicated in  the regulation of antigen loading into MHC II molecules, increased  acidification produces increased proteolysis and efficient peptide  loading. (from UniProt P01920)
HLA-DRB1 (ENST00000328980.11) at chr6_GL000255v2_alt:3779004-3792428 - Binds peptides derived from antigens that access the  endocytic route of antigen presenting cells (APC) and presents  them on the cell surface for recognition by the CD4 T-cells. The  peptide binding cleft accommodates peptides of 10-30 residues. The  peptides presented by MHC class II molecules are generated mostly  by degradation of proteins that access the endocytic route, where  they are processed by lysosomal proteases and other hydrolases.  Exogenous antigens that have been endocytosed by the APC are thus  readily available for presentation via MHC II molecules, and for  this reason this antigen presentation pathway is usually referred  to as exogenous. As membrane proteins on their way to degradation  in lysosomes as part of their normal turn-over are also contained  in the endosomal/lysosomal compartments, exogenous antigens must  compete with those derived from endogenous components. Autophagy  is also a source of endogenous peptides, autophagosomes  constitutively fuse with MHC class II loading compartments. In  addition to APCs, other cells of the gastrointestinal tract, such  as epithelial cells, express MHC class II molecules and CD74 and  act as APCs, which is an unusual trait of the GI tract. To produce  a MHC class II molecule that presents an antigen, three MHC class  II molecules (heterodimers of an alpha and a beta chain) associate  with a CD74 trimer in the ER to form a heterononamer. Soon after  the entry of this complex into the endosomal/lysosomal system  where antigen processing occurs, CD74 undergoes a sequential  degradation by various proteases, including CTSS and CTSL, leaving  a small fragment termed CLIP (class-II-associated invariant chain  peptide). The removal of CLIP is facilitated by HLA-DM via direct  binding to the alpha-beta-CLIP complex so that CLIP is released.  HLA-DM stabilizes MHC class II molecules until primary high  affinity antigenic peptides are bound. The MHC II molecule bound  to a peptide is then transported to the cell membrane surface. In  B-cells, the interaction between HLA-DM and MHC class II molecules  is regulated by HLA-DO. Primary dendritic cells (DCs) also to  express HLA-DO. Lysosomal miroenvironment has been implicated in  the regulation of antigen loading into MHC II molecules, increased  acidification produces increased proteolysis and efficient peptide  loading. (from UniProt Q9GIY3)
HLA-DQA1 (ENST00000444296.6) at chr6_GL000256v2_alt:4039371-4045152 - Binds peptides derived from antigens that access the  endocytic route of antigen presenting cells (APC) and presents  them on the cell surface for recognition by the CD4 T-cells. The  peptide binding cleft accommodates peptides of 10-30 residues. The  peptides presented by MHC class II molecules are generated mostly  by degradation of proteins that access the endocytic route, where  they are processed by lysosomal proteases and other hydrolases.  Exogenous antigens that have been endocytosed by the APC are thus  readily available for presentation via MHC II molecules, and for  this reason this antigen presentation pathway is usually referred  to as exogenous. As membrane proteins on their way to degradation  in lysosomes as part of their normal turn-over are also contained  in the endosomal/lysosomal compartments, exogenous antigens must  compete with those derived from endogenous components. Autophagy  is also a source of endogenous peptides, autophagosomes  constitutively fuse with MHC class II loading compartments. In  addition to APCs, other cells of the gastrointestinal tract, such  as epithelial cells, express MHC class II molecules and CD74 and  act as APCs, which is an unusual trait of the GI tract. To produce  a MHC class II molecule that presents an antigen, three MHC class  II molecules (heterodimers of an alpha and a beta chain) associate  with a CD74 trimer in the ER to form a heterononamer. Soon after  the entry of this complex into the endosomal/lysosomal system  where antigen processing occurs, CD74 undergoes a sequential  degradation by various proteases, including CTSS and CTSL, leaving  a small fragment termed CLIP (class-II-associated invariant chain  peptide). The removal of CLIP is facilitated by HLA-DM via direct  binding to the alpha-beta-CLIP complex so that CLIP is released.  HLA-DM stabilizes MHC class II molecules until primary high  affinity antigenic peptides are bound. The MHC II molecule bound  to a peptide is then transported to the cell membrane surface. In  B-cells, the interaction between HLA-DM and MHC class II molecules  is regulated by HLA-DO. Primary dendritic cells (DCs) also to  express HLA-DO. Lysosomal miroenvironment has been implicated in  the regulation of antigen loading into MHC II molecules, increased  acidification produces increased proteolysis and efficient peptide  loading. (from UniProt P01909)
HLA-DQA1 (ENST00000395363.5) at chr6:32637401-32643652 - Binds peptides derived from antigens that access the  endocytic route of antigen presenting cells (APC) and presents  them on the cell surface for recognition by the CD4 T-cells. The  peptide binding cleft accommodates peptides of 10-30 residues. The  peptides presented by MHC class II molecules are generated mostly  by degradation of proteins that access the endocytic route, where  they are processed by lysosomal proteases and other hydrolases.  Exogenous antigens that have been endocytosed by the APC are thus  readily available for presentation via MHC II molecules, and for  this reason this antigen presentation pathway is usually referred  to as exogenous. As membrane proteins on their way to degradation  in lysosomes as part of their normal turn-over are also contained  in the endosomal/lysosomal compartments, exogenous antigens must  compete with those derived from endogenous components. Autophagy  is also a source of endogenous peptides, autophagosomes  constitutively fuse with MHC class II loading compartments. In  addition to APCs, other cells of the gastrointestinal tract, such  as epithelial cells, express MHC class II molecules and CD74 and  act as APCs, which is an unusual trait of the GI tract. To produce  a MHC class II molecule that presents an antigen, three MHC class  II molecules (heterodimers of an alpha and a beta chain) associate  with a CD74 trimer in the ER to form a heterononamer. Soon after  the entry of this complex into the endosomal/lysosomal system  where antigen processing occurs, CD74 undergoes a sequential  degradation by various proteases, including CTSS and CTSL, leaving  a small fragment termed CLIP (class-II-associated invariant chain  peptide). The removal of CLIP is facilitated by HLA-DM via direct  binding to the alpha-beta-CLIP complex so that CLIP is released.  HLA-DM stabilizes MHC class II molecules until primary high  affinity antigenic peptides are bound. The MHC II molecule bound  to a peptide is then transported to the cell membrane surface. In  B-cells, the interaction between HLA-DM and MHC class II molecules  is regulated by HLA-DO. Primary dendritic cells (DCs) also to  express HLA-DO. Lysosomal miroenvironment has been implicated in  the regulation of antigen loading into MHC II molecules, increased  acidification produces increased proteolysis and efficient peptide  loading. (from UniProt P01909)
HLA-DQA1 (ENST00000374949.2) at chr6:32637420-32643017 - Binds peptides derived from antigens that access the  endocytic route of antigen presenting cells (APC) and presents  them on the cell surface for recognition by the CD4 T-cells. The  peptide binding cleft accommodates peptides of 10-30 residues. The  peptides presented by MHC class II molecules are generated mostly  by degradation of proteins that access the endocytic route, where  they are processed by lysosomal proteases and other hydrolases.  Exogenous antigens that have been endocytosed by the APC are thus  readily available for presentation via MHC II molecules, and for  this reason this antigen presentation pathway is usually referred  to as exogenous. As membrane proteins on their way to degradation  in lysosomes as part of their normal turn-over are also contained  in the endosomal/lysosomal compartments, exogenous antigens must  compete with those derived from endogenous components. Autophagy  is also a source of endogenous peptides, autophagosomes  constitutively fuse with MHC class II loading compartments. In  addition to APCs, other cells of the gastrointestinal tract, such  as epithelial cells, express MHC class II molecules and CD74 and  act as APCs, which is an unusual trait of the GI tract. To produce  a MHC class II molecule that presents an antigen, three MHC class  II molecules (heterodimers of an alpha and a beta chain) associate  with a CD74 trimer in the ER to form a heterononamer. Soon after  the entry of this complex into the endosomal/lysosomal system  where antigen processing occurs, CD74 undergoes a sequential  degradation by various proteases, including CTSS and CTSL, leaving  a small fragment termed CLIP (class-II-associated invariant chain  peptide). The removal of CLIP is facilitated by HLA-DM via direct  binding to the alpha-beta-CLIP complex so that CLIP is released.  HLA-DM stabilizes MHC class II molecules until primary high  affinity antigenic peptides are bound. The MHC II molecule bound  to a peptide is then transported to the cell membrane surface. In  B-cells, the interaction between HLA-DM and MHC class II molecules  is regulated by HLA-DO. Primary dendritic cells (DCs) also to  express HLA-DO. Lysosomal miroenvironment has been implicated in  the regulation of antigen loading into MHC II molecules, increased  acidification produces increased proteolysis and efficient peptide  loading. (from UniProt P01909)
HLA-DRB1 (ENST00000428566.5) at chr6_GL000251v2_alt:4000478-4028652 - Binds peptides derived from antigens that access the  endocytic route of antigen presenting cells (APC) and presents  them on the cell surface for recognition by the CD4 T-cells. The  peptide binding cleft accommodates peptides of 10-30 residues. The  peptides presented by MHC class II molecules are generated mostly  by degradation of proteins that access the endocytic route, where  they are processed by lysosomal proteases and other hydrolases.  Exogenous antigens that have been endocytosed by the APC are thus  readily available for presentation via MHC II molecules, and for  this reason this antigen presentation pathway is usually referred  to as exogenous. As membrane proteins on their way to degradation  in lysosomes as part of their normal turn-over are also contained  in the endosomal/lysosomal compartments, exogenous antigens must  compete with those derived from endogenous components. Autophagy  is also a source of endogenous peptides, autophagosomes  constitutively fuse with MHC class II loading compartments. In  addition to APCs, other cells of the gastrointestinal tract, such  as epithelial cells, express MHC class II molecules and CD74 and  act as APCs, which is an unusual trait of the GI tract. To produce  a MHC class II molecule that presents an antigen, three MHC class  II molecules (heterodimers of an alpha and a beta chain) associate  with a CD74 trimer in the ER to form a heterononamer. Soon after  the entry of this complex into the endosomal/lysosomal system  where antigen processing occurs, CD74 undergoes a sequential  degradation by various proteases, including CTSS and CTSL, leaving  a small fragment termed CLIP (class-II-associated invariant chain  peptide). The removal of CLIP is facilitated by HLA-DM via direct  binding to the alpha-beta-CLIP complex so that CLIP is released.  HLA-DM stabilizes MHC class II molecules until primary high  affinity antigenic peptides are bound. The MHC II molecule bound  to a peptide is then transported to the cell membrane surface. In  B-cells, the interaction between HLA-DM and MHC class II molecules  is regulated by HLA-DO. Primary dendritic cells (DCs) also to  express HLA-DO. Lysosomal miroenvironment has been implicated in  the regulation of antigen loading into MHC II molecules, increased  acidification produces increased proteolysis and efficient peptide  loading. (from UniProt Q9GIY3)
HLA-DRB1 (ENST00000415796.5) at chr6_GL000255v2_alt:3781437-3809621 - Binds peptides derived from antigens that access the  endocytic route of antigen presenting cells (APC) and presents  them on the cell surface for recognition by the CD4 T-cells. The  peptide binding cleft accommodates peptides of 10-30 residues. The  peptides presented by MHC class II molecules are generated mostly  by degradation of proteins that access the endocytic route, where  they are processed by lysosomal proteases and other hydrolases.  Exogenous antigens that have been endocytosed by the APC are thus  readily available for presentation via MHC II molecules, and for  this reason this antigen presentation pathway is usually referred  to as exogenous. As membrane proteins on their way to degradation  in lysosomes as part of their normal turn-over are also contained  in the endosomal/lysosomal compartments, exogenous antigens must  compete with those derived from endogenous components. Autophagy  is also a source of endogenous peptides, autophagosomes  constitutively fuse with MHC class II loading compartments. In  addition to APCs, other cells of the gastrointestinal tract, such  as epithelial cells, express MHC class II molecules and CD74 and  act as APCs, which is an unusual trait of the GI tract. To produce  a MHC class II molecule that presents an antigen, three MHC class  II molecules (heterodimers of an alpha and a beta chain) associate  with a CD74 trimer in the ER to form a heterononamer. Soon after  the entry of this complex into the endosomal/lysosomal system  where antigen processing occurs, CD74 undergoes a sequential  degradation by various proteases, including CTSS and CTSL, leaving  a small fragment termed CLIP (class-II-associated invariant chain  peptide). The removal of CLIP is facilitated by HLA-DM via direct  binding to the alpha-beta-CLIP complex so that CLIP is released.  HLA-DM stabilizes MHC class II molecules until primary high  affinity antigenic peptides are bound. The MHC II molecule bound  to a peptide is then transported to the cell membrane surface. In  B-cells, the interaction between HLA-DM and MHC class II molecules  is regulated by HLA-DO. Primary dendritic cells (DCs) also to  express HLA-DO. Lysosomal miroenvironment has been implicated in  the regulation of antigen loading into MHC II molecules, increased  acidification produces increased proteolysis and efficient peptide  loading. (from UniProt Q9GIY3)
HLA-DQA1 (ENST00000399678.5) at chr6_GL000255v2_alt:3836468-3842664 - Binds peptides derived from antigens that access the  endocytic route of antigen presenting cells (APC) and presents  them on the cell surface for recognition by the CD4 T-cells. The  peptide binding cleft accommodates peptides of 10-30 residues. The  peptides presented by MHC class II molecules are generated mostly  by degradation of proteins that access the endocytic route, where  they are processed by lysosomal proteases and other hydrolases.  Exogenous antigens that have been endocytosed by the APC are thus  readily available for presentation via MHC II molecules, and for  this reason this antigen presentation pathway is usually referred  to as exogenous. As membrane proteins on their way to degradation  in lysosomes as part of their normal turn-over are also contained  in the endosomal/lysosomal compartments, exogenous antigens must  compete with those derived from endogenous components. Autophagy  is also a source of endogenous peptides, autophagosomes  constitutively fuse with MHC class II loading compartments. In  addition to APCs, other cells of the gastrointestinal tract, such  as epithelial cells, express MHC class II molecules and CD74 and  act as APCs, which is an unusual trait of the GI tract. To produce  a MHC class II molecule that presents an antigen, three MHC class  II molecules (heterodimers of an alpha and a beta chain) associate  with a CD74 trimer in the ER to form a heterononamer. Soon after  the entry of this complex into the endosomal/lysosomal system  where antigen processing occurs, CD74 undergoes a sequential  degradation by various proteases, including CTSS and CTSL, leaving  a small fragment termed CLIP (class-II-associated invariant chain  peptide). The removal of CLIP is facilitated by HLA-DM via direct  binding to the alpha-beta-CLIP complex so that CLIP is released.  HLA-DM stabilizes MHC class II molecules until primary high  affinity antigenic peptides are bound. The MHC II molecule bound  to a peptide is then transported to the cell membrane surface. In  B-cells, the interaction between HLA-DM and MHC class II molecules  is regulated by HLA-DO. Primary dendritic cells (DCs) also to  express HLA-DO. Lysosomal miroenvironment has been implicated in  the regulation of antigen loading into MHC II molecules, increased  acidification produces increased proteolysis and efficient peptide  loading. (from UniProt P01909)
HLA-DQA1 (ENST00000399675.5) at chr6_GL000255v2_alt:3836468-3842664 - Binds peptides derived from antigens that access the  endocytic route of antigen presenting cells (APC) and presents  them on the cell surface for recognition by the CD4 T-cells. The  peptide binding cleft accommodates peptides of 10-30 residues. The  peptides presented by MHC class II molecules are generated mostly  by degradation of proteins that access the endocytic route, where  they are processed by lysosomal proteases and other hydrolases.  Exogenous antigens that have been endocytosed by the APC are thus  readily available for presentation via MHC II molecules, and for  this reason this antigen presentation pathway is usually referred  to as exogenous. As membrane proteins on their way to degradation  in lysosomes as part of their normal turn-over are also contained  in the endosomal/lysosomal compartments, exogenous antigens must  compete with those derived from endogenous components. Autophagy  is also a source of endogenous peptides, autophagosomes  constitutively fuse with MHC class II loading compartments. In  addition to APCs, other cells of the gastrointestinal tract, such  as epithelial cells, express MHC class II molecules and CD74 and  act as APCs, which is an unusual trait of the GI tract. To produce  a MHC class II molecule that presents an antigen, three MHC class  II molecules (heterodimers of an alpha and a beta chain) associate  with a CD74 trimer in the ER to form a heterononamer. Soon after  the entry of this complex into the endosomal/lysosomal system  where antigen processing occurs, CD74 undergoes a sequential  degradation by various proteases, including CTSS and CTSL, leaving  a small fragment termed CLIP (class-II-associated invariant chain  peptide). The removal of CLIP is facilitated by HLA-DM via direct  binding to the alpha-beta-CLIP complex so that CLIP is released.  HLA-DM stabilizes MHC class II molecules until primary high  affinity antigenic peptides are bound. The MHC II molecule bound  to a peptide is then transported to the cell membrane surface. In  B-cells, the interaction between HLA-DM and MHC class II molecules  is regulated by HLA-DO. Primary dendritic cells (DCs) also to  express HLA-DO. Lysosomal miroenvironment has been implicated in  the regulation of antigen loading into MHC II molecules, increased  acidification produces increased proteolysis and efficient peptide  loading. (from UniProt P01909)
HLA-DRB1 (ENST00000412634.5) at chr6_GL000256v2_alt:3981401-4012352 - Binds peptides derived from antigens that access the  endocytic route of antigen presenting cells (APC) and presents  them on the cell surface for recognition by the CD4 T-cells. The  peptide binding cleft accommodates peptides of 10-30 residues. The  peptides presented by MHC class II molecules are generated mostly  by degradation of proteins that access the endocytic route, where  they are processed by lysosomal proteases and other hydrolases.  Exogenous antigens that have been endocytosed by the APC are thus  readily available for presentation via MHC II molecules, and for  this reason this antigen presentation pathway is usually referred  to as exogenous. As membrane proteins on their way to degradation  in lysosomes as part of their normal turn-over are also contained  in the endosomal/lysosomal compartments, exogenous antigens must  compete with those derived from endogenous components. Autophagy  is also a source of endogenous peptides, autophagosomes  constitutively fuse with MHC class II loading compartments. In  addition to APCs, other cells of the gastrointestinal tract, such  as epithelial cells, express MHC class II molecules and CD74 and  act as APCs, which is an unusual trait of the GI tract. To produce  a MHC class II molecule that presents an antigen, three MHC class  II molecules (heterodimers of an alpha and a beta chain) associate  with a CD74 trimer in the ER to form a heterononamer. Soon after  the entry of this complex into the endosomal/lysosomal system  where antigen processing occurs, CD74 undergoes a sequential  degradation by various proteases, including CTSS and CTSL, leaving  a small fragment termed CLIP (class-II-associated invariant chain  peptide). The removal of CLIP is facilitated by HLA-DM via direct  binding to the alpha-beta-CLIP complex so that CLIP is released.  HLA-DM stabilizes MHC class II molecules until primary high  affinity antigenic peptides are bound. The MHC II molecule bound  to a peptide is then transported to the cell membrane surface. In  B-cells, the interaction between HLA-DM and MHC class II molecules  is regulated by HLA-DO. Primary dendritic cells (DCs) also to  express HLA-DO. Lysosomal miroenvironment has been implicated in  the regulation of antigen loading into MHC II molecules, increased  acidification produces increased proteolysis and efficient peptide  loading. (from UniProt Q9GIY3)
PRKAR1A (ENST00000588188.6) at chr17:68515400-68551319 - Homo sapiens protein kinase cAMP-dependent type I regulatory subunit alpha (PRKAR1A), transcript variant 5, mRNA. (from RefSeq NM_001276290)
TBC1D25 (ENST00000376771.9) at chrX:48539714-48562609 - Homo sapiens TBC1 domain family member 25 (TBC1D25), transcript variant 14, non-coding RNA. (from RefSeq NR_145502)
PRKAR1A (ENST00000392711.5) at chr17:68512379-68533423 - Homo sapiens protein kinase cAMP-dependent type I regulatory subunit alpha (PRKAR1A), transcript variant 3, mRNA. (from RefSeq NM_212472)
PRKAR1A (ENST00000589228.5) at chr17:68512427-68533431 - Homo sapiens protein kinase cAMP-dependent type I regulatory subunit alpha (PRKAR1A), transcript variant 8, mRNA. (from RefSeq NM_001369390)
PRKAR1A (ENST00000536854.6) at chr17:68512450-68532762 - Homo sapiens protein kinase cAMP-dependent type I regulatory subunit alpha (PRKAR1A), transcript variant 4, mRNA. (from RefSeq NM_001276289)
PRKAR1A (ENST00000358598.6) at chr17:68512032-68532762 - Homo sapiens protein kinase cAMP-dependent type I regulatory subunit alpha (PRKAR1A), transcript variant 2, mRNA. (from RefSeq NM_212471)
KHSRP (ENST00000398148.7) at chr19:6413348-6424794 - Homo sapiens KH-type splicing regulatory protein (KHSRP), transcript variant 1, mRNA. (from RefSeq NM_003685)
FREM1 (ENST00000427623.5) at chr9:14737366-14774161 - Extracellular matrix protein that plays a role in  epidermal differentiation and is required for epidermal adhesion  during embryonic development (By similarity). (from UniProt Q5H8C1)
ARL6 (ENST00000394206.5) at chr3:97764521-97798535 - Homo sapiens ADP ribosylation factor like GTPase 6 (ARL6), transcript variant 2, mRNA. (from RefSeq NM_177976)
ARL6 (ENST00000335979.6) at chr3:97764521-97798535 - Homo sapiens ADP ribosylation factor like GTPase 6 (ARL6), transcript variant 1, mRNA. (from RefSeq NM_032146)
FREM1 (ENST00000422223.6) at chr9:14734666-14910995 - Homo sapiens FRAS1 related extracellular matrix 1 (FREM1), transcript variant 1, mRNA. (from RefSeq NM_144966)
FREM1 (ENST00000380894.5) at chr9:14737152-14779533 - Homo sapiens FRAS1 related extracellular matrix 1 (FREM1), transcript variant 5, mRNA. (from RefSeq NM_001370061)
ARL6 (ENST00000493990.5) at chr3:97764521-97801109 - Homo sapiens ADP ribosylation factor like GTPase 6 (ARL6), transcript variant 12, non-coding RNA. (from RefSeq NR_136602)
ARL6 (ENST00000463745.6) at chr3:97764758-97801229 - Homo sapiens ADP ribosylation factor like GTPase 6 (ARL6), transcript variant 9, non-coding RNA. (from RefSeq NR_136598)
HLA-DQB2 (ENST00000430849.6) at chr6_GL000252v2_alt:4000854-4008293 - Homo sapiens major histocompatibility complex, class II, DQ beta 2 (HLA-DQB2), transcript variant 1, mRNA. (from RefSeq NM_001300790)
HLA-DQB2 (ENST00000457432.6) at chr6_GL000253v2_alt:4175450-4182889 - Homo sapiens major histocompatibility complex, class II, DQ beta 2 (HLA-DQB2), transcript variant 1, mRNA. (from RefSeq NM_001300790)
HLA-DQB2 (ENST00000432486.6) at chr6_GL000254v2_alt:4055473-4062912 - Homo sapiens major histocompatibility complex, class II, DQ beta 2 (HLA-DQB2), transcript variant 1, mRNA. (from RefSeq NM_001300790)
HLA-DQB2 (ENST00000399661.4) at chr6_GL000255v2_alt:3950399-3957838 - Homo sapiens major histocompatibility complex, class II, DQ beta 2 (HLA-DQB2), transcript variant 1, mRNA. (from RefSeq NM_001300790)
HLA-DQB2 (ENST00000456529.1) at chr6_GL000250v2_alt:4062237-4069630 - Homo sapiens major histocompatibility complex, class II, DQ beta 2 (HLA-DQB2), transcript variant 2, mRNA. (from RefSeq NM_001198858)
HLA-DQB2 (ENST00000438757.1) at chr6_GL000251v2_alt:4169671-4177064 - Homo sapiens major histocompatibility complex, class II, DQ beta 2 (HLA-DQB2), transcript variant 2, mRNA. (from RefSeq NM_001198858)
HLA-DQB2 (ENST00000426733.5) at chr6_GL000256v2_alt:4156243-4163635 - Homo sapiens major histocompatibility complex, class II, DQ beta 2 (HLA-DQB2), transcript variant 2, mRNA. (from RefSeq NM_001198858)
HLA-DQB2 (ENST00000411527.5) at chr6:32756098-32763490 - Homo sapiens major histocompatibility complex, class II, DQ beta 2 (HLA-DQB2), transcript variant 2, mRNA. (from RefSeq NM_001198858)
HLA-DQA2 (ENST00000453672.2) at chr6_GL000253v2_alt:4160657-4166218 - Homo sapiens major histocompatibility complex, class II, DQ alpha 2 (HLA-DQA2), mRNA. (from RefSeq NM_020056)
HLA-DQA2 (ENST00000446482.2) at chr6_GL000255v2_alt:3935606-3941465 - Homo sapiens major histocompatibility complex, class II, DQ alpha 2 (HLA-DQA2), mRNA. (from RefSeq NM_020056)
HLA-DQA2 (ENST00000241802.9) at chr6_GL000254v2_alt:4040716-4046584 - Homo sapiens major histocompatibility complex, class II, DQ alpha 2 (HLA-DQA2), mRNA. (from RefSeq NM_020056)
HLA-DQA2 (ENST00000415898.2) at chr6_GL000256v2_alt:4141489-4147359 - Homo sapiens major histocompatibility complex, class II, DQ alpha 2 (HLA-DQA2), mRNA. (from RefSeq NM_020056)
FREM1 (ENST00000380880.3) at chr9:14737396-14910430 - Homo sapiens FRAS1 related extracellular matrix 1 (FREM1), transcript variant 9, non-coding RNA. (from RefSeq NR_163239)
HLA-DRA (ENST00000383127.6) at chr6_GL000251v2_alt:3877968-3883135 - Homo sapiens major histocompatibility complex, class II, DR alpha (HLA-DRA), mRNA. (from RefSeq NM_019111)
HLA-DRA (ENST00000416883.6) at chr6_GL000252v2_alt:3680147-3685357 - Homo sapiens major histocompatibility complex, class II, DR alpha (HLA-DRA), mRNA. (from RefSeq NM_019111)
HLA-DRA (ENST00000442960.6) at chr6_GL000253v2_alt:3744059-3749270 - Homo sapiens major histocompatibility complex, class II, DR alpha (HLA-DRA), mRNA. (from RefSeq NM_019111)
HLA-DRA (ENST00000414698.6) at chr6_GL000254v2_alt:3780808-3786018 - Homo sapiens major histocompatibility complex, class II, DR alpha (HLA-DRA), mRNA. (from RefSeq NM_019111)
HLA-DRA (ENST00000383259.6) at chr6_GL000255v2_alt:3662891-3668101 - Homo sapiens major histocompatibility complex, class II, DR alpha (HLA-DRA), mRNA. (from RefSeq NM_019111)
HLA-DRA (ENST00000411524.6) at chr6_GL000256v2_alt:3754985-3760195 - Homo sapiens major histocompatibility complex, class II, DR alpha (HLA-DRA), mRNA. (from RefSeq NM_019111)
HLA-DRA (ENST00000395388.7) at chr6:32439887-32445046 - Homo sapiens major histocompatibility complex, class II, DR alpha (HLA-DRA), mRNA. (from RefSeq NM_019111)
HLA-DRB1 (ENST00000444645.6) at chr6_GL000252v2_alt:3814543-3830112 - Homo sapiens major histocompatibility complex, class II, DR beta 1 (HLA-DRB1), transcript variant 3, mRNA. (from RefSeq NM_001359193)
HLA-DRB1 (ENST00000437784.6) at chr6_GL000253v2_alt:3988943-4004557 - Homo sapiens major histocompatibility complex, class II, DR beta 1 (HLA-DRB1), transcript variant 3, mRNA. (from RefSeq NM_001359193)
GABARAPL1 (ENST00000421801.6) at chr12:10212836-10220831 - Homo sapiens GABA type A receptor associated protein like 1 (GABARAPL1), transcript variant 1, mRNA. (from RefSeq NM_001363598)
GABARAPL1 (ENST00000266458.10) at chr12:10212877-10223128 - Homo sapiens GABA type A receptor associated protein like 1 (GABARAPL1), transcript variant 2, mRNA. (from RefSeq NM_031412)
GABARAPL1 (ENST00000545887.1) at chr12:10212928-10221969 - Increases cell-surface expression of kappa-type opioid  receptor through facilitating anterograde intracellular  trafficking of the receptor. Involved in formation of  autophagosomal vacuoles. (from UniProt Q9H0R8)
GABARAPL1 (ENST00000543602.5) at chr12:10212883-10220778 - Increases cell-surface expression of kappa-type opioid  receptor through facilitating anterograde intracellular  trafficking of the receptor. Involved in formation of  autophagosomal vacuoles. (from UniProt Q9H0R8)
HLA-DRB4 (ENST00000411565.2) at chr6_GL000256v2_alt:3851133-3866096 - Homo sapiens major histocompatibility complex, class II, DR beta 4 (HLA-DRB4), mRNA. (from RefSeq NM_021983)
HLA-DQA1 (ENST00000418023.5) at chr6_GL000256v2_alt:4039288-4045152 - Homo sapiens major histocompatibility complex, class II, DQ alpha 1 (HLA-DQA1), mRNA. (from RefSeq NM_002122)
HLA-DQA1 (ENST00000383251.6) at chr6_GL000255v2_alt:3836385-3842664 - Homo sapiens major histocompatibility complex, class II, DQ alpha 1 (HLA-DQA1), mRNA. (from RefSeq NM_002122)
HLA-DQA1 (ENST00000343139.10) at chr6:32637406-32643671 - Homo sapiens major histocompatibility complex, class II, DQ alpha 1 (HLA-DQA1), mRNA. (from RefSeq NM_002122)
HLA-DQB1 (ENST00000419914.6) at chr6_GL000253v2_alt:4076917-4084516 - Homo sapiens major histocompatibility complex, class II, DQ beta 1 (HLA-DQB1), transcript variant 3, mRNA. (from RefSeq NM_001243962)
HLA-DRB5 (ENST00000374975.4) at chr6:32517353-32530287 - Homo sapiens major histocompatibility complex, class II, DR beta 5 (HLA-DRB5), mRNA. (from RefSeq NM_002125)
HLA-DRB3 (ENST00000383126.7) at chr6_GL000251v2_alt:3934009-3947126 - Homo sapiens major histocompatibility complex, class II, DR beta 3 (HLA-DRB3), mRNA. (from RefSeq NM_022555)
HLA-DRB3 (ENST00000307137.11) at chr6_GL000255v2_alt:3715358-3728445 - Homo sapiens major histocompatibility complex, class II, DR beta 3 (HLA-DRB3), mRNA. (from RefSeq NM_022555)
HLA-DRB1 (ENST00000399450.6) at chr6_GL000251v2_alt:3998045-4011459 - Homo sapiens major histocompatibility complex, class II, DR beta 1 (HLA-DRB1), transcript variant 2, mRNA. (from RefSeq NM_001243965)
HLA-DRB1 (ENST00000419393.6) at chr6_GL000256v2_alt:3979128-3993834 - Homo sapiens major histocompatibility complex, class II, DR beta 1 (HLA-DRB1), transcript variant 4, mRNA. (from RefSeq NM_001359194)
HLA-DPB1 (ENST00000454006.6) at chr6_GL000252v2_alt:4319457-4330724 - Homo sapiens major histocompatibility complex, class II, DP beta 1 (HLA-DPB1), mRNA. (from RefSeq NM_002121)
HLA-DPB1 (ENST00000399500.6) at chr6_GL000255v2_alt:4270558-4281835 - Homo sapiens major histocompatibility complex, class II, DP beta 1 (HLA-DPB1), mRNA. (from RefSeq NM_002121)
HLA-DPB1 (ENST00000433800.6) at chr6_GL000256v2_alt:4524909-4536184 - Homo sapiens major histocompatibility complex, class II, DP beta 1 (HLA-DPB1), mRNA. (from RefSeq NM_002121)
HLA-DPB1 (ENST00000418931.7) at chr6:33075990-33089696 - Homo sapiens major histocompatibility complex, class II, DP beta 1 (HLA-DPB1), mRNA. (from RefSeq NM_002121)
SRSF10 (ENST00000495785.1) at chr1:23971339-23980271 - serine and arginine rich splicing factor 10 (from HGNC SRSF10)
SRSF10 (ENST00000374453.7) at chr1:23967618-23980294 - Homo sapiens serine and arginine rich splicing factor 10 (SRSF10), transcript variant 8, mRNA. (from RefSeq NM_001300936)
SRSF10 (ENST00000492112.3) at chr1:23964347-23980327 - Homo sapiens serine and arginine rich splicing factor 10 (SRSF10), transcript variant 2, mRNA. (from RefSeq NM_054016)
SRSF10 (ENST00000484146.6) at chr1:23967173-23980356 - Homo sapiens serine and arginine rich splicing factor 10 (SRSF10), transcript variant 6, mRNA. (from RefSeq NM_001191009)
SRSF10 (ENST00000453840.7) at chr1:23966445-23980296 - Homo sapiens serine and arginine rich splicing factor 10 (SRSF10), transcript variant 5, mRNA. (from RefSeq NM_001191007)
SRSF10 (ENST00000374452.9) at chr1:23967307-23980308 - Homo sapiens serine and arginine rich splicing factor 10 (SRSF10), transcript variant 4, mRNA. (from RefSeq NM_001191006)
SRSF10 (ENST00000344989.10) at chr1:23964804-23980331 - Homo sapiens serine and arginine rich splicing factor 10 (SRSF10), transcript variant 1, mRNA. (from RefSeq NM_006625)
SRSF10 (ENST00000343255.9) at chr1:23969083-23980327 - Homo sapiens serine and arginine rich splicing factor 10 (SRSF10), transcript variant 3, mRNA. (from RefSeq NM_001191005)
TCHHL1 (ENST00000368806.2) at chr1:152084141-152089064 - Homo sapiens trichohyalin like 1 (TCHHL1), mRNA. (from RefSeq NM_001008536)
CRNN (ENST00000271835.3) at chr1:152409243-152414263 - Homo sapiens cornulin (CRNN), mRNA. (from RefSeq NM_016190)
AKTIP (ENST00000300245.8) at chr16:53491379-53503244 - Homo sapiens AKT interacting protein (AKTIP), transcript variant 3, mRNA. (from RefSeq NM_001308325)
AKTIP (ENST00000394657.12) at chr16:53491040-53503209 - Homo sapiens AKT interacting protein (AKTIP), transcript variant 2, mRNA. (from RefSeq NM_022476)
MLLT11 (ENST00000368921.4) at chr1:151057758-151068497 - Homo sapiens MLLT11 transcription factor 7 cofactor (MLLT11), mRNA. (from RefSeq NM_006818)
TNFSF12-TNFSF13 (ENST00000293826.4) at chr17:7549099-7561601 - Homo sapiens TNFSF12-TNFSF13 readthrough (TNFSF12-TNFSF13), mRNA. (from RefSeq NM_172089)
UNC13D (ENST00000412096.6) at chr17:75827264-75844350 - Plays a role in cytotoxic granule exocytosis in  lymphocytes. Required for both granule maturation and granule  docking and priming at the immunologic synapse. Regulates assembly  of recycling and late endosomal structures, leading to the  formation of an endosomal exocytic compartment that fuses with  perforin-containing granules at the immunologic synapse and  licences them for exocytosis. Regulates Ca(2+)-dependent secretory  lysosome exocytosis in mast cells. (from UniProt Q70J99)
KIAA1549 (ENST00000440172.5) at chr7:138831381-138981318 - Homo sapiens KIAA1549 (KIAA1549), transcript variant 1, mRNA. (from RefSeq NM_020910)
NR5A2 (ENST00000544748.5) at chr1:200042825-200177420 - Homo sapiens nuclear receptor subfamily 5 group A member 2 (NR5A2), transcript variant 3, mRNA. (from RefSeq NM_001276464)
KIAA1549 (ENST00000422774.1) at chr7:138837525-138981318 - Homo sapiens KIAA1549 (KIAA1549), transcript variant 2, mRNA. (from RefSeq NM_001164665)
NR5A2 (ENST00000236914.7) at chr1:200027614-200175603 - Homo sapiens nuclear receptor subfamily 5 group A member 2 (NR5A2), transcript variant 2, mRNA. (from RefSeq NM_003822)
NR5A2 (ENST00000367362.8) at chr1:200027710-200177415 - Homo sapiens nuclear receptor subfamily 5 group A member 2 (NR5A2), transcript variant 1, mRNA. (from RefSeq NM_205860)
ERC1 (ENST00000355446.9) at chr12:1027772-1492487 - Homo sapiens ELKS/RAB6-interacting/CAST family member 1 (ERC1), transcript variant zeta, mRNA. (from RefSeq NM_001301248)
LHFPL6 (ENST00000379589.4) at chr13:39342892-39603193 - Homo sapiens LHFPL tetraspan subfamily member 6 (LHFPL6), mRNA. (from RefSeq NM_005780)
SS18L2 (ENST00000447630.5) at chr3:42581840-42595114 - Homo sapiens SS18 like 2 (SS18L2), transcript variant 2, mRNA. (from RefSeq NM_016305)
SS18L2 (ENST00000011691.5) at chr3:42590838-42594996 - Homo sapiens SS18 like 2 (SS18L2), transcript variant 1, mRNA. (from RefSeq NM_001370300)
LHFPL3 (ENST00000424859.6) at chr7:104328789-104907232 - Homo sapiens LHFPL tetraspan subfamily member 3 (LHFPL3), mRNA. (from RefSeq NM_199000)
ERC1 (ENST00000545948.5) at chr12:991273-1490377 - Homo sapiens ELKS/RAB6-interacting/CAST family member 1 (ERC1), transcript variant gamma, non-coding RNA. (from RefSeq NR_027949)
ERC1 (ENST00000440394.7) at chr12:991267-1493549 - Homo sapiens ELKS/RAB6-interacting/CAST family member 1 (ERC1), transcript variant beta, non-coding RNA. (from RefSeq NR_027948)
ERC1 (ENST00000347735.10) at chr12:991238-1491567 - Homo sapiens ELKS/RAB6-interacting/CAST family member 1 (ERC1), transcript variant alpha, non-coding RNA. (from RefSeq NR_027946)
LHFPL4 (ENST00000287585.8) at chr3:9498361-9553822 - Homo sapiens LHFPL tetraspan subfamily member 4 (LHFPL4), mRNA. (from RefSeq NM_198560)
ERC1 (ENST00000543086.7) at chr12:991208-1495933 - Homo sapiens ELKS/RAB6-interacting/CAST family member 1 (ERC1), transcript variant delta, mRNA. (from RefSeq NM_178039)
ERC1 (ENST00000360905.9) at chr12:991223-1495931 - Homo sapiens ELKS/RAB6-interacting/CAST family member 1 (ERC1), transcript variant epsilon, mRNA. (from RefSeq NM_178040)
CREB3L2 (ENST00000330387.11) at chr7:137874979-138002086 - Homo sapiens cAMP responsive element binding protein 3 like 2 (CREB3L2), transcript variant 1, mRNA. (from RefSeq NM_194071)
CREB3L2 (ENST00000452463.5) at chr7:137912811-138002047 - Homo sapiens cAMP responsive element binding protein 3 like 2 (CREB3L2), transcript variant 2, mRNA. (from RefSeq NM_001253775)
LHFPL2 (ENST00000380345.7) at chr5:78485230-78648772 - Homo sapiens LHFPL tetraspan subfamily member 2 (LHFPL2), mRNA. (from RefSeq NM_005779)
TSN (ENST00000478165.5) at chr2:121755660-121765221 - Homo sapiens translin (TSN), transcript variant 6, non-coding RNA. (from RefSeq NR_048559)
LHFPL1 (ENST00000371968.8) at chrX:112630648-112679938 - Homo sapiens LHFPL tetraspan subfamily member 1 (LHFPL1), mRNA. (from RefSeq NM_178175)
TSN (ENST00000536142.5) at chr2:121755545-121767853 - Homo sapiens translin (TSN), transcript variant 2, mRNA. (from RefSeq NM_001261401)
RPS27A (ENST00000404735.1) at chr2:55232678-55235755 - Homo sapiens ribosomal protein S27a (RPS27A), transcript variant 3, mRNA. (from RefSeq NM_001177413)
RPS27A (ENST00000402285.7) at chr2:55231903-55235588 - Homo sapiens ribosomal protein S27a (RPS27A), transcript variant 2, mRNA. (from RefSeq NM_001135592)
TSN (ENST00000389682.8) at chr2:121755651-121767853 - Homo sapiens translin (TSN), transcript variant 3, non-coding RNA. (from RefSeq NR_048556)
FASN (ENST00000306749.4) at chr17:82078338-82098236 - Homo sapiens fatty acid synthase (FASN), mRNA. (from RefSeq NM_004104)
RPS27A (ENST00000272317.10) at chr2:55232402-55235853 - Homo sapiens ribosomal protein S27a (RPS27A), transcript variant 1, mRNA. (from RefSeq NM_002954)
CBFA2T2 (ENST00000397800.5) at chr20:33562365-33650031 - Homo sapiens CBFA2/RUNX1 partner transcriptional co-repressor 2 (CBFA2T2), transcript variant 4, mRNA. (from RefSeq NM_001039709)
CBFA2T2 (ENST00000346541.7) at chr20:33562365-33650031 - Homo sapiens CBFA2/RUNX1 partner transcriptional co-repressor 2 (CBFA2T2), transcript variant 2, mRNA. (from RefSeq NM_005093)
CBFA2T2 (ENST00000342704.10) at chr20:33490087-33645541 - Homo sapiens CBFA2/RUNX1 partner transcriptional co-repressor 2 (CBFA2T2), transcript variant 3, mRNA. (from RefSeq NM_001032999)
NAPG (ENST00000322897.11) at chr18:10526027-10552764 - Homo sapiens NSF attachment protein gamma (NAPG), mRNA. (from RefSeq NM_003826)
AATF (ENST00000620004.2) at chr17_KI270857v1_alt:1185240-1293236 - Homo sapiens apoptosis antagonizing transcription factor (AATF), mRNA. (from RefSeq NM_012138)
AFF3 (ENST00000409579.5) at chr2:99551121-100106128 - Homo sapiens AF4/FMR2 family member 3 (AFF3), transcript variant 2, mRNA. (from RefSeq NM_001025108)
FOXD4L1 (ENST00000306507.6) at chr2:113498665-113501155 - Homo sapiens forkhead box D4 like 1 (FOXD4L1), mRNA. (from RefSeq NM_012184)
AATF (ENST00000619387.5) at chr17:36948954-37056871 - Homo sapiens apoptosis antagonizing transcription factor (AATF), mRNA. (from RefSeq NM_012138)
UBB (ENST00000614404.1) at chr17:16381465-16382742 - Homo sapiens ubiquitin B (UBB), transcript variant 3, mRNA. (from RefSeq NM_001281717)
UBB (ENST00000395839.5) at chr17:16381290-16382740 - Homo sapiens ubiquitin B (UBB), transcript variant 5, mRNA. (from RefSeq NM_001281719)
UBB (ENST00000395837.1) at chr17:16381341-16382740 - Homo sapiens ubiquitin B (UBB), transcript variant 4, mRNA. (from RefSeq NM_001281718)
AFF3 (ENST00000317233.8) at chr2:99547256-100142575 - Homo sapiens AF4/FMR2 family member 3 (AFF3), transcript variant 1, mRNA. (from RefSeq NM_002285)
RUNX1T1 (ENST00000615601.4) at chr8:91954967-92103226 - Homo sapiens RUNX1 partner transcriptional co-repressor 1 (RUNX1T1), transcript variant 13, mRNA. (from RefSeq NM_001198633)
RUNX1T1 (ENST00000436581.6) at chr8:91954967-92095654 - Homo sapiens RUNX1 partner transcriptional co-repressor 1 (RUNX1T1), transcript variant 15, mRNA. (from RefSeq NM_001198679)
UBA52 (ENST00000599551.5) at chr19:18572740-18575241 - Homo sapiens ubiquitin A-52 residue ribosomal protein fusion product 1 (UBA52), transcript variant 7, mRNA. (from RefSeq NM_001321021)
UBA52 (ENST00000596304.5) at chr19:18571730-18575202 - Homo sapiens ubiquitin A-52 residue ribosomal protein fusion product 1 (UBA52), transcript variant 3, mRNA. (from RefSeq NM_001321017)
UBB (ENST00000302182.8) at chr17:16381091-16382740 - Homo sapiens ubiquitin B (UBB), transcript variant 1, mRNA. (from RefSeq NM_018955)
RUNX1T1 (ENST00000422361.6) at chr8:91959793-92017637 - Homo sapiens RUNX1 partner transcriptional co-repressor 1 (RUNX1T1), transcript variant 4, mRNA. (from RefSeq NM_175636)
RUNX1T1 (ENST00000360348.6) at chr8:91959787-92095215 - Homo sapiens RUNX1 partner transcriptional co-repressor 1 (RUNX1T1), transcript variant 3, mRNA. (from RefSeq NM_175635)
UBA52 (ENST00000442744.7) at chr19:18571857-18577550 - Homo sapiens ubiquitin A-52 residue ribosomal protein fusion product 1 (UBA52), transcript variant 2, mRNA. (from RefSeq NM_003333)
FEV (ENST00000295727.1) at chr2:218981087-218985657 - Homo sapiens FEV transcription factor, ETS family member (FEV), mRNA. (from RefSeq NM_017521)
ZNF136 (ENST00000343979.6) at chr19:12163096-12189871 - Homo sapiens zinc finger protein 136 (ZNF136), transcript variant 1, mRNA. (from RefSeq NM_003437)
RUNX1T1 (ENST00000617740.4) at chr8:91954967-92095654 - Homo sapiens RUNX1 partner transcriptional co-repressor 1 (RUNX1T1), transcript variant 10, mRNA. (from RefSeq NM_001198629)
RUNX1T1 (ENST00000614812.4) at chr8:91954967-92095654 - Homo sapiens RUNX1 partner transcriptional co-repressor 1 (RUNX1T1), transcript variant 12, mRNA. (from RefSeq NM_001198631)
RUNX1T1 (ENST00000613302.4) at chr8:91954967-92095654 - Homo sapiens RUNX1 partner transcriptional co-repressor 1 (RUNX1T1), transcript variant 11, mRNA. (from RefSeq NM_001198630)
RUNX1T1 (ENST00000265814.4) at chr8:91954967-92099688 - Homo sapiens RUNX1 partner transcriptional co-repressor 1 (RUNX1T1), transcript variant 9, mRNA. (from RefSeq NM_001198628)
CBFA2T3 (ENST00000327483.9) at chr16:88874858-88941198 - Homo sapiens CBFA2/RUNX1 partner transcriptional co-repressor 3 (CBFA2T3), transcript variant 2, mRNA. (from RefSeq NM_175931)
RUNX1T1 (ENST00000523629.5) at chr8:91954975-92103226 - Homo sapiens RUNX1 partner transcriptional co-repressor 1 (RUNX1T1), transcript variant 2, mRNA. (from RefSeq NM_175634)
CBFA2T3 (ENST00000268679.9) at chr16:88874858-88977207 - Homo sapiens CBFA2/RUNX1 partner transcriptional co-repressor 3 (CBFA2T3), transcript variant 1, mRNA. (from RefSeq NM_005187)
EWSR1 (ENST00000414183.6) at chr22:29268316-29300343 - Homo sapiens EWS RNA binding protein 1 (EWSR1), transcript variant 1, mRNA. (from RefSeq NM_013986)
RUNX1T1 (ENST00000613886.4) at chr8:91954967-92095262 - Homo sapiens RUNX1 partner transcriptional co-repressor 1 (RUNX1T1), transcript variant 1, mRNA. (from RefSeq NM_004349)
RUNX1T1 (ENST00000520724.5) at chr8:91960131-92095611 - Homo sapiens RUNX1 partner transcriptional co-repressor 1 (RUNX1T1), transcript variant 14, mRNA. (from RefSeq NM_001198634)
EWSR1 (ENST00000406548.5) at chr22:29268273-29300336 - Homo sapiens EWS RNA binding protein 1 (EWSR1), transcript variant 3, mRNA. (from RefSeq NM_001163285)
EWSR1 (ENST00000397938.6) at chr22:29268018-29300525 - Homo sapiens EWS RNA binding protein 1 (EWSR1), transcript variant 2, mRNA. (from RefSeq NM_005243)
EWSR1 (ENST00000332035.10) at chr22:29268326-29300336 - Homo sapiens EWS RNA binding protein 1 (EWSR1), transcript variant 4, mRNA. (from RefSeq NM_001163286)
RUNX1T1 (ENST00000518844.5) at chr8:91960242-92095613 - Homo sapiens RUNX1 partner transcriptional co-repressor 1 (RUNX1T1), transcript variant 5, mRNA. (from RefSeq NM_001198625)
EWSR1 (ENST00000333395.10) at chr22:29268318-29290684 - Homo sapiens EWS RNA binding protein 1 (EWSR1), transcript variant 5, mRNA. (from RefSeq NM_001163287)
TMEM189 (ENST00000371650.9) at chr20:50123737-50153734 - Homo sapiens transmembrane protein 189 (TMEM189), transcript variant 2, mRNA. (from RefSeq NM_001162505)
ABL1 (ENST00000372348.7) at chr9:130713016-130885683 - Homo sapiens ABL proto-oncogene 1, non-receptor tyrosine kinase (ABL1), transcript variant b, mRNA. (from RefSeq NM_007313)
TMEM189 (ENST00000371652.9) at chr20:50118254-50153723 - Homo sapiens transmembrane protein 189 (TMEM189), transcript variant 1, mRNA. (from RefSeq NM_199129)
ABL1 (ENST00000318560.6) at chr9:130835254-130887675 - Homo sapiens ABL proto-oncogene 1, non-receptor tyrosine kinase (ABL1), transcript variant a, mRNA. (from RefSeq NM_005157)
TFG (ENST00000620299.4) at chr3:100709331-100747448 -   O15162:PLSCR1; NbExp=2; IntAct=EBI-357061, EBI-740019; (from UniProt Q92734)
TFG (ENST00000418917.6) at chr3:100709361-100748942 -   O15162:PLSCR1; NbExp=2; IntAct=EBI-357061, EBI-740019; (from UniProt Q92734)
TFG (ENST00000615993.1) at chr3:100713686-100748531 -   O15162:PLSCR1; NbExp=2; IntAct=EBI-357061, EBI-740019; (from UniProt Q92734)
PATZ1 (ENST00000405309.7) at chr22:31325809-31346232 - Homo sapiens POZ/BTB and AT hook containing zinc finger 1 (PATZ1), transcript variant 3, mRNA. (from RefSeq NM_032052)
PATZ1 (ENST00000351933.8) at chr22:31325809-31346232 - Homo sapiens POZ/BTB and AT hook containing zinc finger 1 (PATZ1), transcript variant 2, mRNA. (from RefSeq NM_032050)
PATZ1 (ENST00000215919.3) at chr22:31340677-31345776 - Homo sapiens POZ/BTB and AT hook containing zinc finger 1 (PATZ1), transcript variant 4, mRNA. (from RefSeq NM_032051)
PATZ1 (ENST00000266269.10) at chr22:31325804-31346346 - Homo sapiens POZ/BTB and AT hook containing zinc finger 1 (PATZ1), transcript variant 1, mRNA. (from RefSeq NM_014323)
PDGFRB (ENST00000261799.9) at chr5:150113839-150155845 - Homo sapiens platelet derived growth factor receptor beta (PDGFRB), transcript variant 1, mRNA. (from RefSeq NM_002609)
RPL22 (ENST00000234875.9) at chr1:6185020-6199595 - Homo sapiens ribosomal protein L22 (RPL22), mRNA. (from RefSeq NM_000983)
SMOC1 (ENST00000381280.4) at chr14:69879426-70032366 - Homo sapiens SPARC related modular calcium binding 1 (SMOC1), transcript variant 2, mRNA. (from RefSeq NM_022137)
SMOC1 (ENST00000361956.7) at chr14:69879416-70030727 - Homo sapiens SPARC related modular calcium binding 1 (SMOC1), transcript variant 1, mRNA. (from RefSeq NM_001034852)
TFG (ENST00000490574.5) at chr3:100709378-100748927 - Homo sapiens trafficking from ER to golgi regulator (TFG), transcript variant 2, mRNA. (from RefSeq NM_001007565)
TFG (ENST00000476228.5) at chr3:100709606-100748964 - Homo sapiens trafficking from ER to golgi regulator (TFG), transcript variant 4, mRNA. (from RefSeq NM_001195479)
TFG (ENST00000240851.9) at chr3:100709494-100748964 - Homo sapiens trafficking from ER to golgi regulator (TFG), transcript variant 1, mRNA. (from RefSeq NM_006070)
RPL7A (ENST00000630979.3) at chr9_KN196479v1_fix:174312-177520 - Homo sapiens ribosomal protein L7a (RPL7A), mRNA. (from RefSeq NM_000972)
RPL7A (ENST00000323345.11) at chr9:133348218-133351426 - Homo sapiens ribosomal protein L7a (RPL7A), mRNA. (from RefSeq NM_000972)
GMPR (ENST00000259727.5) at chr6:16238587-16295549 - Homo sapiens guanosine monophosphate reductase (GMPR), mRNA. (from RefSeq NM_006877)
HMGA2 (ENST00000537429.5) at chr12:65824460-65881890 - Functions as a transcriptional regulator. Functions in  cell cycle regulation through CCNA2. Plays an important role in  chromosome condensation during the meiotic G2/M transition of  spermatocytes (By similarity). (from UniProt P52926)
HMGA2 (ENST00000537275.5) at chr12:65824460-65842917 - Functions as a transcriptional regulator. Functions in  cell cycle regulation through CCNA2. Plays an important role in  chromosome condensation during the meiotic G2/M transition of  spermatocytes (By similarity). (from UniProt P52926)
HMGA2 (ENST00000425208.6) at chr12:65824460-65882126 - Functions as a transcriptional regulator. Functions in  cell cycle regulation through CCNA2. Plays an important role in  chromosome condensation during the meiotic G2/M transition of  spermatocytes (By similarity). (from UniProt P52926)
CEP85L (ENST00000360290.7) at chr6:118491431-118652520 - Cytoplasm, cytoskeleton, centrosome  (Probable). Note=Subcellular experiments using a GFP-tagged system  produced a weak signal, rendering it difficult to confirm  centrosome association. (from UniProt Q5SZL2)
CEP85L (ENST00000392500.7) at chr6:118491431-118710068 - Cytoplasm, cytoskeleton, centrosome  (Probable). Note=Subcellular experiments using a GFP-tagged system  produced a weak signal, rendering it difficult to confirm  centrosome association. (from UniProt Q5SZL2)
UNC13D (ENST00000207549.8) at chr17:75827225-75844717 - Homo sapiens unc-13 homolog D (UNC13D), mRNA. (from RefSeq NM_199242)
CHRFAM7A (ENST00000299847.6) at chr15:30357766-30393549 - Homo sapiens CHRNA7 (exons 5-10) and FAM7A (exons A-E) fusion (CHRFAM7A), transcript variant 1, mRNA. (from RefSeq NM_139320)
CEP85L (ENST00000368488.9) at chr6:118460781-118710075 - Homo sapiens centrosomal protein 85 like (CEP85L), transcript variant 3, mRNA. (from RefSeq NM_001178035)
CEP85L (ENST00000368491.8) at chr6:118460772-118651591 - Homo sapiens centrosomal protein 85 like (CEP85L), transcript variant 1, mRNA. (from RefSeq NM_001042475)
CEP85L (ENST00000419517.2) at chr6:118491632-118651857 - Homo sapiens centrosomal protein 85 like (CEP85L), transcript variant 2, mRNA. (from RefSeq NM_206921)
GDF5 (ENST00000374372.1) at chr20:35433347-35454746 - Homo sapiens growth differentiation factor 5 (GDF5), transcript variant 1, mRNA. (from RefSeq NM_001319138)
CDH11 (ENST00000394156.7) at chr16:64943753-65122036 - Homo sapiens cadherin 11 (CDH11), transcript variant 2, mRNA. (from RefSeq NM_001308392)
CDH11 (ENST00000268603.9) at chr16:64943753-65122063 - Homo sapiens cadherin 11 (CDH11), transcript variant 1, mRNA. (from RefSeq NM_001797)
GDF5 (ENST00000374369.8) at chr20:35433347-35438228 - Homo sapiens growth differentiation factor 5 (GDF5), transcript variant 2, mRNA. (from RefSeq NM_000557)
WDR35 (ENST00000281405.8) at chr2:19910260-19990122 - Homo sapiens WD repeat domain 35 (WDR35), transcript variant 2, mRNA. (from RefSeq NM_020779)
WDR35 (ENST00000345530.7) at chr2:19910260-19990131 - Homo sapiens WD repeat domain 35 (WDR35), transcript variant 1, mRNA. (from RefSeq NM_001006657)
MLF1 (ENST00000478894.7) at chr3:158571254-158605401 - Homo sapiens myeloid leukemia factor 1 (MLF1), transcript variant 4, mRNA. (from RefSeq NM_001195432)
MLF1 (ENST00000477042.6) at chr3:158571194-158605403 - Homo sapiens myeloid leukemia factor 1 (MLF1), transcript variant 11, mRNA. (from RefSeq NM_001369785)
MLF1 (ENST00000484955.5) at chr3:158571173-158605397 - Homo sapiens myeloid leukemia factor 1 (MLF1), transcript variant 10, mRNA. (from RefSeq NM_001369784)
MLF1 (ENST00000471745.5) at chr3:158571194-158605392 - Homo sapiens myeloid leukemia factor 1 (MLF1), transcript variant 6, mRNA. (from RefSeq NM_001195434)
MLF1 (ENST00000469452.5) at chr3:158571195-158605399 - Homo sapiens myeloid leukemia factor 1 (MLF1), transcript variant 5, mRNA. (from RefSeq NM_001195433)
MLF1 (ENST00000359117.9) at chr3:158571184-158606456 - Homo sapiens myeloid leukemia factor 1 (MLF1), transcript variant 3, mRNA. (from RefSeq NM_001130156)
MLF1 (ENST00000355893.11) at chr3:158571194-158606456 - Homo sapiens myeloid leukemia factor 1 (MLF1), transcript variant 1, mRNA. (from RefSeq NM_022443)
MLF1 (ENST00000651874.1) at chr3:158571567-158605402 - Involved in lineage commitment of primary hemopoietic  progenitors by restricting erythroid formation and enhancing  myeloid formation. Interferes with erythropoietin-induced  erythroid terminal differentiation by preventing cells from  exiting the cell cycle through suppression of CDKN1B/p27Kip1  levels. Suppresses RFWD2/COP1 activity via CSN3 which activates  p53 and induces cell cycle arrest. Binds DNA and affects the  expression of a number of genes so may function as a transcription  factor in the nucleus. (from UniProt P58340)
MLF1 (ENST00000618075.4) at chr3:158571164-158606459 - Involved in lineage commitment of primary hemopoietic  progenitors by restricting erythroid formation and enhancing  myeloid formation. Interferes with erythropoietin-induced  erythroid terminal differentiation by preventing cells from  exiting the cell cycle through suppression of CDKN1B/p27Kip1  levels. Suppresses RFWD2/COP1 activity via CSN3 which activates  p53 and induces cell cycle arrest. Binds DNA and affects the  expression of a number of genes so may function as a transcription  factor in the nucleus. (from UniProt P58340)
MLF1 (ENST00000482628.5) at chr3:158571210-158605218 - Involved in lineage commitment of primary hemopoietic  progenitors by restricting erythroid formation and enhancing  myeloid formation. Interferes with erythropoietin-induced  erythroid terminal differentiation by preventing cells from  exiting the cell cycle through suppression of CDKN1B/p27Kip1  levels. Suppresses RFWD2/COP1 activity via CSN3 which activates  p53 and induces cell cycle arrest. Binds DNA and affects the  expression of a number of genes so may function as a transcription  factor in the nucleus. (from UniProt P58340)
MLF1 (ENST00000392822.4) at chr3:158582835-158606459 - Involved in lineage commitment of primary hemopoietic  progenitors by restricting erythroid formation and enhancing  myeloid formation. Interferes with erythropoietin-induced  erythroid terminal differentiation by preventing cells from  exiting the cell cycle through suppression of CDKN1B/p27Kip1  levels. Suppresses RFWD2/COP1 activity via CSN3 which activates  p53 and induces cell cycle arrest. Binds DNA and affects the  expression of a number of genes so may function as a transcription  factor in the nucleus. (from UniProt P58340)
TFE3 (ENST00000493583.5) at chrX:49028726-49043410 - Transcription factor that specifically recognizes and  binds E-box sequences (5'-CANNTG-3'). Efficient DNA-binding  requires dimerization with itself or with another MiT/TFE family  member such as TFEB or MITF. In association with TFEB, activates  the expression of CD40L in T-cells, thereby playing a role in T-  cell-dependent antibody responses in activated CD4(+) T-cells and  thymus-dependent humoral immunity. Specifically recognizes the  MUE3 box, a subset of E-boxes, present in the immunoglobulin  enhancer. It also binds very well to a USF/MLTF site. (from UniProt P19532)
HMGA2 (ENST00000393578.7) at chr12:65824460-65843523 - Homo sapiens high mobility group AT-hook 2 (HMGA2), transcript variant 5, mRNA. (from RefSeq NM_001330190)
HMGA2 (ENST00000354636.7) at chr12:65824460-65915527 - Homo sapiens high mobility group AT-hook 2 (HMGA2), transcript variant 2, mRNA. (from RefSeq NM_003484)
HMGA2 (ENST00000403681.6) at chr12:65824131-65966295 - Homo sapiens high mobility group AT-hook 2 (HMGA2), transcript variant 1, mRNA. (from RefSeq NM_003483)
LPP (ENST00000640853.1) at chr3:188212933-188890671 - Homo sapiens LIM domain containing preferred translocation partner in lipoma (LPP), transcript variant 1, mRNA. (from RefSeq NM_005578)
RECQL4 (ENST00000617875.5) at chr8:144511288-144517833 - Homo sapiens RecQ like helicase 4 (RECQL4), mRNA. (from RefSeq NM_004260)
LPP (ENST00000617246.4) at chr3:188225405-188890671 - Homo sapiens LIM domain containing preferred translocation partner in lipoma (LPP), transcript variant 3, mRNA. (from RefSeq NM_001167672)
TFE3 (ENST00000315869.8) at chrX:49028726-49043357 - Homo sapiens transcription factor binding to IGHM enhancer 3 (TFE3), transcript variant 1, mRNA. (from RefSeq NM_006521)
SRPX2 (ENST00000373004.5) at chrX:100644199-100675788 - Homo sapiens sushi repeat containing protein X-linked 2 (SRPX2), mRNA. (from RefSeq NM_014467)
USP6 (ENST00000574788.5) at chr17:5116438-5174991 - Homo sapiens ubiquitin specific peptidase 6 (USP6), transcript variant 1, mRNA. (from RefSeq NM_001304284)
USP6 (ENST00000250066.6) at chr17:5128392-5175034 - Homo sapiens ubiquitin specific peptidase 6 (USP6), transcript variant 2, mRNA. (from RefSeq NM_004505)
HOXD13 (ENST00000392539.4) at chr2:176092721-176095944 - Homo sapiens homeobox D13 (HOXD13), mRNA. (from RefSeq NM_000523)
USP6 (ENST00000572949.5) at chr17:5128392-5175032 - Deubiquitinase with an ATP-independent isopeptidase  activity, cleaving at the C-terminus of the ubiquitin moiety.  Catalyzes its own deubiquitination. In vitro, isoform 2, but not  isoform 3, shows deubiquitinating activity. Promotes plasma  membrane localization of ARF6 and selectively regulates ARF6-  dependent endocytic protein trafficking. Is able to initiate  tumorigenesis by inducing the production of matrix  metalloproteinases following NF-kappa-B activation. (from UniProt P35125)
UBC (ENST00000339647.6) at chr12:124911646-124914650 - Homo sapiens ubiquitin C (UBC), mRNA. (from RefSeq NM_021009)
IHH (ENST00000295731.7) at chr2:219054424-219060921 - Homo sapiens Indian hedgehog signaling molecule (IHH), mRNA. (from RefSeq NM_002181)
UBC (ENST00000536769.1) at chr12:124911604-124915348 - Ubiquitin exists either covalently attached to another  protein, or free (unanchored). When covalently bound, it is  conjugated to target proteins via an isopeptide bond either as a  monomer (monoubiquitin), a polymer linked via different Lys  residues of the ubiquitin (polyubiquitin chains) or a linear  polymer linked via the initiator Met of the ubiquitin (linear  polyubiquitin chains). Polyubiquitin chains, when attached to a  target protein, have different functions depending on the Lys  residue of the ubiquitin that is linked: Lys-6-linked may be  involved in DNA repair; Lys-11-linked is involved in ERAD  (endoplasmic reticulum-associated degradation) and in cell-cycle  regulation; Lys-29-linked is involved in lysosomal degradation;  Lys-33-linked is involved in kinase modification; Lys-48-linked is  involved in protein degradation via the proteasome; Lys-63-linked  is involved in endocytosis, DNA-damage responses as well as in  signaling processes leading to activation of the transcription  factor NF-kappa-B. Linear polymer chains formed via attachment by  the initiator Met lead to cell signaling. Ubiquitin is usually  conjugated to Lys residues of target proteins, however, in rare  cases, conjugation to Cys or Ser residues has been observed. When  polyubiquitin is free (unanchored-polyubiquitin), it also has  distinct roles, such as in activation of protein kinases, and in  signaling. (from UniProt P0CG48)
UBE2V1 (ENST00000415862.6) at chr20:50081124-50115954 - Homo sapiens ubiquitin conjugating enzyme E2 V1 (UBE2V1), transcript variant 3, mRNA. (from RefSeq NM_022442)
UBE2V1 (ENST00000371657.9) at chr20:50081124-50113139 - Homo sapiens ubiquitin conjugating enzyme E2 V1 (UBE2V1), transcript variant 8, mRNA. (from RefSeq NM_001257396)
UBE2V1 (ENST00000371674.7) at chr20:50081124-50113173 - Homo sapiens ubiquitin conjugating enzyme E2 V1 (UBE2V1), transcript variant 15, mRNA. (from RefSeq NM_001282577)
UBE2V1 (ENST00000371677.7) at chr20:50081124-50115954 - Homo sapiens ubiquitin conjugating enzyme E2 V1 (UBE2V1), transcript variant 2, mRNA. (from RefSeq NM_199144)
UBE2V1 (ENST00000340309.7) at chr20:50081124-50115954 - Homo sapiens ubiquitin conjugating enzyme E2 V1 (UBE2V1), transcript variant 1, mRNA. (from RefSeq NM_021988)
PLAG1 (ENST00000423799.6) at chr8:56166099-56211300 - Homo sapiens PLAG1 zinc finger (PLAG1), transcript variant 3, mRNA. (from RefSeq NM_001114635)
PLAG1 (ENST00000316981.8) at chr8:56160909-56211273 - Homo sapiens PLAG1 zinc finger (PLAG1), transcript variant 1, mRNA. (from RefSeq NM_002655)
PLAG1 (ENST00000429357.2) at chr8:56166243-56211300 - Transcription factor whose activation results in up-  regulation of target genes, such as IGFII, leading to uncontrolled  cell proliferation: when overexpressed in cultured cells, higher  proliferation rate and transformation are observed. Other target  genes such as CRLF1, CRABP2, CRIP2, PIGF are strongly induced in  cells with PLAG1 induction. Proto-oncogene whose ectopic  expression can trigger the development of pleomorphic adenomas of  the salivary gland and lipoblastomas. Overexpression is associated  with up-regulation of IGFII, is frequently observed in  hepatoblastoma, common primary liver tumor in childhood.  Cooperates with CBFB-MYH11, a fusion gene important for myeloid  leukemia. (from UniProt Q6DJT9)
GJA1 (ENST00000649003.1) at chr6:121435595-121449715 - Gap junction protein that acts as a regulator of bladder  capacity. A gap junction consists of a cluster of closely packed  pairs of transmembrane channels, the connexons, through which  materials of low MW diffuse from one cell to a neighboring cell.  May play a critical role in the physiology of hearing by  participating in the recycling of potassium to the cochlear  endolymph. Negative regulator of bladder functional capacity: acts  by enhancing intercellular electrical and chemical transmission,  thus sensitizing bladder muscles to cholinergic neural stimuli and  causing them to contract (By similarity). (from UniProt P17302)
GJA1 (ENST00000650427.1) at chr6:121437382-121449705 - Gap junction protein that acts as a regulator of bladder  capacity. A gap junction consists of a cluster of closely packed  pairs of transmembrane channels, the connexons, through which  materials of low MW diffuse from one cell to a neighboring cell.  May play a critical role in the physiology of hearing by  participating in the recycling of potassium to the cochlear  endolymph. Negative regulator of bladder functional capacity: acts  by enhancing intercellular electrical and chemical transmission,  thus sensitizing bladder muscles to cholinergic neural stimuli and  causing them to contract (By similarity). (from UniProt P17302)
GJA1 (ENST00000647564.1) at chr6:121437499-121448812 - Gap junction protein that acts as a regulator of bladder  capacity. A gap junction consists of a cluster of closely packed  pairs of transmembrane channels, the connexons, through which  materials of low MW diffuse from one cell to a neighboring cell.  May play a critical role in the physiology of hearing by  participating in the recycling of potassium to the cochlear  endolymph. Negative regulator of bladder functional capacity: acts  by enhancing intercellular electrical and chemical transmission,  thus sensitizing bladder muscles to cholinergic neural stimuli and  causing them to contract (By similarity). (from UniProt P17302)
MEGF10 (ENST00000508365.5) at chr5:127290846-127424781 - Homo sapiens multiple EGF like domains 10 (MEGF10), transcript variant 4, mRNA. (from RefSeq NM_001308121)
MEGF10 (ENST00000418761.6) at chr5:127290847-127424604 - Homo sapiens multiple EGF like domains 10 (MEGF10), transcript variant 3, mRNA. (from RefSeq NM_001308119)
MEGF10 (ENST00000274473.6) at chr5:127290859-127461222 - Homo sapiens multiple EGF like domains 10 (MEGF10), transcript variant 1, mRNA. (from RefSeq NM_032446)
MEGF10 (ENST00000503335.7) at chr5:127290796-127461222 - Homo sapiens multiple EGF like domains 10 (MEGF10), transcript variant 2, mRNA. (from RefSeq NM_001256545)
RNF139 (ENST00000303545.3) at chr8:124474738-124487914 - Homo sapiens ring finger protein 139 (RNF139), mRNA. (from RefSeq NM_007218)
RUNX1 (ENST00000300305.7) at chr21:34787801-35049344 - CBF binds to the core site, 5'-PYGPYGGT-3', of a number  of enhancers and promoters, including murine leukemia virus,  polyomavirus enhancer, T-cell receptor enhancers, LCK, IL-3 and  GM-CSF promoters. The alpha subunit binds DNA and appears to have  a role in the development of normal hematopoiesis. Isoform AML-1L  interferes with the transactivation activity of RUNX1. Acts  synergistically with ELF4 to transactivate the IL-3 promoter and  with ELF2 to transactivate the mouse BLK promoter. Inhibits KAT6B-  dependent transcriptional activation. (from UniProt Q01196)
RUNX1 (ENST00000358356.9) at chr21:34821279-34888690 - Homo sapiens RUNX family transcription factor 1 (RUNX1), transcript variant 3, mRNA. (from RefSeq NM_001122607)
RUNX1 (ENST00000437180.5) at chr21:34787801-35049298 - Homo sapiens RUNX family transcription factor 1 (RUNX1), transcript variant 1, mRNA. (from RefSeq NM_001754)
RUNX1 (ENST00000344691.8) at chr21:34787801-34888690 - Homo sapiens RUNX family transcription factor 1 (RUNX1), transcript variant 2, mRNA. (from RefSeq NM_001001890)
GJA1 (ENST00000282561.4) at chr6:121435646-121449727 - Homo sapiens gap junction protein alpha 1 (GJA1), mRNA. (from RefSeq NM_000165)
NRG1 (ENST00000650919.1) at chr8:32548235-32743253 - Homo sapiens neuregulin 1 (NRG1), transcript variant HRG-beta3, mRNA. (from RefSeq NM_013958)
NRG1 (ENST00000523079.5) at chr8:32548210-32760989 - Homo sapiens neuregulin 1 (NRG1), transcript variant HRG-beta2b, mRNA. (from RefSeq NM_001160008)
NRG1 (ENST00000519301.6) at chr8:31639222-32764405 - Homo sapiens neuregulin 1 (NRG1), transcript variant fetal-c-IV-2, mRNA. (from RefSeq NM_001322202)
NRG1 (ENST00000287842.7) at chr8:32548635-32764407 - Homo sapiens neuregulin 1 (NRG1), transcript variant HRG-beta1, mRNA. (from RefSeq NM_013956)
NRG1 (ENST00000521670.5) at chr8:32548619-32763998 - Homo sapiens neuregulin 1 (NRG1), transcript variant ndf43, mRNA. (from RefSeq NM_013960)
NRG1 (ENST00000405005.7) at chr8:32548727-32764471 - Homo sapiens neuregulin 1 (NRG1), transcript variant HRG-alpha, mRNA. (from RefSeq NM_013964)
NRG1 (ENST00000356819.7) at chr8:32548267-32767959 - Homo sapiens neuregulin 1 (NRG1), transcript variant HRG-beta2, mRNA. (from RefSeq NM_013957)
NRG1 (ENST00000520407.5) at chr8:31639755-32743224 - Homo sapiens neuregulin 1 (NRG1), transcript variant GGF2, mRNA. (from RefSeq NM_013962)
NRG1 (ENST00000520502.7) at chr8:32647103-32743207 - Homo sapiens neuregulin 1 (NRG1), transcript variant SMDF, mRNA. (from RefSeq NM_013959)
NSF (ENST00000486366.1) at chr17:46590760-46630643 - N-ethylmaleimide sensitive factor, vesicle fusing ATPase (from HGNC NSF)
NSF (ENST00000465370.1) at chr17:46726556-46755837 - N-ethylmaleimide sensitive factor, vesicle fusing ATPase (from HGNC NSF)
NSF (ENST00000629856.1) at chr17_GL000258v2_alt:1576830-1616677 - N-ethylmaleimide sensitive factor, vesicle fusing ATPase (from HGNC NSF)
NSF (ENST00000628495.1) at chr17_GL000258v2_alt:1712447-1741714 - N-ethylmaleimide sensitive factor, vesicle fusing ATPase (from HGNC NSF)
NSF (ENST00000634068.1) at chr17_KI270908v1_alt:1110437-1150316 - N-ethylmaleimide sensitive factor, vesicle fusing ATPase (from HGNC NSF)
NSF (ENST00000633902.1) at chr17_KI270908v1_alt:1232577-1270993 - N-ethylmaleimide sensitive factor, vesicle fusing ATPase (from HGNC NSF)
NSF (ENST00000632862.1) at chr17_KI270908v1_alt:1245985-1275249 - N-ethylmaleimide sensitive factor, vesicle fusing ATPase (from HGNC NSF)
NSF (ENST00000398238.8) at chr17:46590669-46757464 - Homo sapiens N-ethylmaleimide sensitive factor, vesicle fusing ATPase (NSF), transcript variant 2, non-coding RNA. (from RefSeq NR_040116)
NSF (ENST00000611398.3) at chr17_GL000258v2_alt:1576739-1743341 - Homo sapiens N-ethylmaleimide sensitive factor, vesicle fusing ATPase (NSF), transcript variant 2, non-coding RNA. (from RefSeq NR_040116)
NSF (ENST00000620290.2) at chr17_KI270908v1_alt:1110346-1276876 - Homo sapiens N-ethylmaleimide sensitive factor, vesicle fusing ATPase (NSF), transcript variant 2, non-coding RNA. (from RefSeq NR_040116)
FGFR1OP (ENST00000622353.4) at chr6:166999317-167042418 - Homo sapiens FGFR1 oncogene partner (FGFR1OP), transcript variant 3, mRNA. (from RefSeq NM_001278690)
FGFR1OP (ENST00000349556.4) at chr6:166999408-167040317 - Homo sapiens FGFR1 oncogene partner (FGFR1OP), transcript variant 2, mRNA. (from RefSeq NM_194429)
FGFR1OP (ENST00000366847.9) at chr6:166999397-167052718 - Homo sapiens FGFR1 oncogene partner (FGFR1OP), transcript variant 1, mRNA. (from RefSeq NM_007045)
HLF (ENST00000573945.5) at chr17:55266222-55322989 - Homo sapiens HLF transcription factor, PAR bZIP family member (HLF), transcript variant 2, mRNA. (from RefSeq NM_001330375)
HLF (ENST00000226067.10) at chr17:55264960-55325187 - Homo sapiens HLF transcription factor, PAR bZIP family member (HLF), transcript variant 1, mRNA. (from RefSeq NM_002126)
RLF (ENST00000372771.5) at chr1:40161387-40240921 - Homo sapiens rearranged L-myc fusion (RLF), mRNA. (from RefSeq NM_012421)
TPM3 (ENST00000651641.1) at chr1:154161813-154192100 - Homo sapiens tropomyosin 3 (TPM3), transcript variant Tpm3.12, mRNA. (from RefSeq NM_152263)
TPM3 (ENST00000368531.6) at chr1:154158609-154183130 - Homo sapiens tropomyosin 3 (TPM3), transcript variant Tpm3.7, mRNA. (from RefSeq NM_001043352)
TPM3 (ENST00000330188.13) at chr1:154156364-154183205 - Homo sapiens tropomyosin 3 (TPM3), transcript variant Tpm3.2, mRNA. (from RefSeq NM_001043351)
TPM3 (ENST00000302206.9) at chr1:154157583-154178183 - Homo sapiens tropomyosin 3 (TPM3), transcript variant 9, mRNA. (from RefSeq NM_001278191)
TPM3 (ENST00000323144.12) at chr1:154158612-154183203 - Homo sapiens tropomyosin 3 (TPM3), transcript variant Tpm3.4, mRNA. (from RefSeq NM_001043353)
TPM3 (ENST00000368533.8) at chr1:154155308-154183189 - Homo sapiens tropomyosin 3 (TPM3), transcript variant 10, non-coding RNA. (from RefSeq NR_103461)
TPM3 (ENST00000328159.9) at chr1:154156969-154183205 - Homo sapiens tropomyosin 3 (TPM3), transcript variant 17, mRNA. (from RefSeq NM_001364683)
NTRK1 (ENST00000524377.5) at chr1:156860894-156881642 - Homo sapiens neurotrophic receptor tyrosine kinase 1 (NTRK1), transcript variant 2, mRNA. (from RefSeq NM_002529)
NTRK1 (ENST00000392302.6) at chr1:156815656-156881794 - Homo sapiens neurotrophic receptor tyrosine kinase 1 (NTRK1), transcript variant 3, mRNA. (from RefSeq NM_001007792)

NCBI RefSeq genes, curated subset (NM_*, NR_*, NP_* or YP_*)

NM_001170634.1 at chr16:31180110-31194871
NM_001170937.1 at chr16:31180110-31194871
NR_028388.2 at chr16:31180110-31194871
NM_004960.3 at chr16:31180110-31194871

NCBI RefSeq genes, predicted subset (XM_* or XR_*)

XM_011545781.1 at chr16:31180138-31191605
XM_024450221.1 at chr16:31180139-31191605
XM_005255233.5 at chr16:31180155-31191605
XM_011545782.2 at chr16:31184372-31191605

RefSeq Genes

FUS at chr16:31180110-31194871 - (NR_028388) 
STIMATE-MUSTN1 at chr3:52833121-52897548 - (NM_001198974) TMEM110-MUSTN1 fusion protein
ERCC6 at chr10:49515105-49539123 - (NM_001277058) ERCC6-PGBD3 fusion protein isoform 1
FUS at chr16:31180110-31194871 - (NM_001170937) RNA-binding protein FUS isoform 3
ERCC6 at chr10:49515105-49539538 - (NM_001277059) ERCC6-PGBD3 fusion protein isoform 1
FUS at chr16:31180110-31194871 - (NM_004960) RNA-binding protein FUS isoform 1
FUS at chr16:31180110-31194871 - (NM_001170634) RNA-binding protein FUS isoform 2
NSF at chr17_KI270908v1_alt:1110346-1276874 - (NM_006178) vesicle-fusing ATPase
NSF at chr17:46590669-46757462 - (NM_006178) vesicle-fusing ATPase
NSF at chr17_GL000258v2_alt:1576739-1743339 - (NM_006178) vesicle-fusing ATPase
CHRFAM7A at chr15:30361240-30393661 - (NM_148911) CHRNA7-FAM7A fusion protein isoform 2
CHRFAM7A at chr15_KI270905v1_alt:2646214-2678539 - (NM_148911) CHRNA7-FAM7A fusion protein isoform 2
CHRFAM7A at chr15_KN538374v1_fix:2533730-2566055 - (NM_148911) CHRNA7-FAM7A fusion protein isoform 2
ARPIN-AP3S2 at chr15:89830599-89912952 - (NM_001199058) C15orf38-AP3S2 fusion protein
LNP1 at chr3:100401539-100456319 - (NM_001085451) leukemia NUP98 fusion partner 1
SUFU at chr10:102503972-102619467 - (NM_001178133) suppressor of fused homolog isoform 2
SUFU at chr10:102503962-102633457 - (NM_016169) suppressor of fused homolog isoform 1
TFPT at chr19_GL949749v2_alt:81433-90168 - (NM_013342) TCF3 fusion partner isoform 1
TFPT at chr19_GL949747v2_alt:81433-90168 - (NM_013342) TCF3 fusion partner isoform 1
TFPT at chr19_GL949753v2_alt:81433-90168 - (NM_013342) TCF3 fusion partner isoform 1
TFPT at chr19_GL949752v1_alt:81433-90168 - (NM_013342) TCF3 fusion partner isoform 1
TFPT at chr19_KI270938v1_alt:81433-90168 - (NM_013342) TCF3 fusion partner isoform 1
TFPT at chr19_GL949746v1_alt:81433-90168 - (NM_013342) TCF3 fusion partner isoform 1
TFPT at chr19:54107013-54115675 - (NM_013342) TCF3 fusion partner isoform 1
TFPT at chr19_GL949751v2_alt:81433-90168 - (NM_013342) TCF3 fusion partner isoform 1
TFPT at chr19_GL949750v2_alt:81433-90168 - (NM_013342) TCF3 fusion partner isoform 1
TFPT at chr19_GL949748v2_alt:81433-90168 - (NM_013342) TCF3 fusion partner isoform 1
MON1A at chr3:49908869-49930012 - (NM_032355) vacuolar fusion protein MON1 homolog A isoform a
MON1A at chr3:49908869-49930012 - (NM_001142501) vacuolar fusion protein MON1 homolog A isoform b
CHRFAM7A at chr15:30361240-30393661 - (NM_139320) CHRNA7-FAM7A fusion protein isoform 1
CHRFAM7A at chr15_KN538374v1_fix:2533730-2566055 - (NM_139320) CHRNA7-FAM7A fusion protein isoform 1
CHRFAM7A at chr15_KI270905v1_alt:2646214-2678539 - (NM_139320) CHRNA7-FAM7A fusion protein isoform 1
CCZ1B at chr7:6798935-6826295 - (NM_198097) vacuolar fusion protein CCZ1 homolog B
IZUMO1 at chr19:48740852-48746909 - (NM_182575) izumo sperm-egg fusion protein 1 isoform 1 precursor
CCZ1 at chr7:5898733-5926550 - (NM_015622) vacuolar fusion protein CCZ1 homolog
IZUMO1R at chr11:94305637-94307692 - (NM_001199206) sperm-egg fusion protein Juno precursor
FPGT-TNNI3K at chr1:74198212-74464925 - (NM_001199327) FPGT-TNNI3K fusion protein isoform b
LY75-CD302 at chr2:159768628-159904756 - (NM_001198760) LY75-CD302 fusion protein isoform 2 precursor
ARPC4-TTLL3 at chr3:9792548-9836356 - (NM_001198793) ARPC4-TTLL3 fusion protein
FPGT-TNNI3K at chr1:74198212-74544432 - (NM_001112808) FPGT-TNNI3K fusion protein isoform a
MSANTD3-TMEFF1 at chr9:100441906-100577636 - (NM_001198812) MSANTD3-TMEFF1 fusion protein
LY75-CD302 at chr2:159768628-159904756 - (NM_001198759) LY75-CD302 fusion protein isoform 1 precursor
IZUMO3 at chr9:24543215-24545676 - (NM_001271706) izumo sperm-egg fusion protein 3 isoform 1 precursor
IZUMO3 at chr9:24542952-24545897 - (NM_001365008) izumo sperm-egg fusion protein 3 isoform 2 precursor
IZUMO1 at chr19:48740888-48746909 - (NM_001321864) izumo sperm-egg fusion protein 1 isoform 2
IZUMO2 at chr19:50152548-50163281 - (NM_001321449) izumo sperm-egg fusion protein 2 isoform 2 precursor
IZUMO1 at chr19:48740888-48745932 - (NM_001321865) izumo sperm-egg fusion protein 1 isoform 3
TFPT at chr19_GL949751v2_alt:81433-89567 - (NM_001321792) TCF3 fusion partner isoform 2
TFPT at chr19_GL949750v2_alt:81433-89567 - (NM_001321792) TCF3 fusion partner isoform 2
TFPT at chr19_GL949749v2_alt:81433-89567 - (NM_001321792) TCF3 fusion partner isoform 2
TFPT at chr19_GL949748v2_alt:81433-89567 - (NM_001321792) TCF3 fusion partner isoform 2
TFPT at chr19_GL949753v2_alt:81433-89567 - (NM_001321792) TCF3 fusion partner isoform 2
TFPT at chr19_GL949752v1_alt:81433-89567 - (NM_001321792) TCF3 fusion partner isoform 2
TFPT at chr19:54107013-54115074 - (NM_001321792) TCF3 fusion partner isoform 2
TFPT at chr19_GL949747v2_alt:81433-89567 - (NM_001321792) TCF3 fusion partner isoform 2
TFPT at chr19_GL949746v1_alt:81433-89567 - (NM_001321792) TCF3 fusion partner isoform 2
TFPT at chr19_KI270938v1_alt:81433-89567 - (NM_001321792) TCF3 fusion partner isoform 2
MON1B at chr16:77191190-77202398 - (NM_001286639) vacuolar fusion protein MON1 homolog B isoform 2
MON1B at chr16:77191190-77202398 - (NM_014940) vacuolar fusion protein MON1 homolog B isoform 1
MON1B at chr16:77191190-77202398 - (NM_001286640) vacuolar fusion protein MON1 homolog B isoform 3
EPPIN-WFDC6 at chr20:45536280-45547401 - (NM_001198986) SPINLW1-WFDC6 fusion protein precursor
IZUMO4 at chr19:2096915-2099590 - (NM_001031735) izumo sperm-egg fusion protein 4 isoform 1 precursor
POMZP3 at chr7_KI270809v1_alt:96821-114138 - (NM_152992) POM121 and ZP3 fusion protein isoform 2
POMZP3 at chr7:76609986-76627303 - (NM_152992) POM121 and ZP3 fusion protein isoform 2
IZUMO4 at chr19:2096915-2099590 - (NM_001039846) izumo sperm-egg fusion protein 4 isoform 3 precursor
POMZP3 at chr7:76609986-76627303 - (NM_012230) POM121 and ZP3 fusion protein isoform 1
POMZP3 at chr7_KI270809v1_alt:96821-114138 - (NM_012230) POM121 and ZP3 fusion protein isoform 1
IZUMO2 at chr19:50152548-50163281 - (NM_152358) izumo sperm-egg fusion protein 2 isoform 1 precursor
IZUMO4 at chr19:2096915-2099590 - (NM_001363588) izumo sperm-egg fusion protein 4 isoform 4 precursor
PRR5-ARHGAP8 at chr22:44702198-44862784 - (NM_181334) PRR5-ARHGAP8 fusion protein
TMEM189-UBE2V1 at chr20:50081124-50153798 - (NM_199203) TMEM189-UBE2V1 fusion protein
ATP5MF-PTCD1 at chr7:99416739-99466167 - (NM_001198879) ATP5J2-PTCD1 fusion protein

NCBI RefSeq genes, curated subset (NM_*, NR_*, NP_* or YP_*)

izumo sperm-egg fusion 1, transcript variant 4 at chr19:48740888-48745932 - (NR_135832.1)
N-ethylmaleimide sensitive factor, vesicle fusing ATPase, transcript variant 2 at chr17_KI270908v1_alt:1110346-1276876 - (NR_040116.1)
N-ethylmaleimide sensitive factor, vesicle fusing ATPase, transcript variant 2 at chr17_GL000258v2_alt:1576739-1743341 - (NR_040116.1)
N-ethylmaleimide sensitive factor, vesicle fusing ATPase, transcript variant 2 at chr17:46590669-46757464 - (NR_040116.1)
izumo sperm-egg fusion 1, transcript variant 1 at chr19:48740888-48746909 - (NM_182575.2)
CHRNA7 (exons 5-10) and FAM7A (exons A-E) fusion, transcript variant 2 at chr15_KN538374v1_fix:2533730-2566055 - (NM_148911.1)
CHRNA7 (exons 5-10) and FAM7A (exons A-E) fusion, transcript variant 2 at chr15_KI270905v1_alt:2646214-2678539 - (NM_148911.1)
CHRNA7 (exons 5-10) and FAM7A (exons A-E) fusion, transcript variant 2 at chr15:30361240-30393661 - (NM_148911.1)
TCF3 fusion partner, transcript variant 1 at chr19_KI270938v1_alt:81433-90168 - (NM_013342.3)
TCF3 fusion partner, transcript variant 1 at chr19_GL949753v2_alt:81433-90168 - (NM_013342.3)
TCF3 fusion partner, transcript variant 1 at chr19_GL949752v1_alt:81433-90168 - (NM_013342.3)
TCF3 fusion partner, transcript variant 1 at chr19_GL949751v2_alt:81433-90168 - (NM_013342.3)
TCF3 fusion partner, transcript variant 1 at chr19_GL949750v2_alt:81433-90168 - (NM_013342.3)
TCF3 fusion partner, transcript variant 1 at chr19_GL949749v2_alt:81433-90168 - (NM_013342.3)
TCF3 fusion partner, transcript variant 1 at chr19_GL949748v2_alt:81433-90168 - (NM_013342.3)
TCF3 fusion partner, transcript variant 1 at chr19_GL949747v2_alt:81433-90168 - (NM_013342.3)
TCF3 fusion partner, transcript variant 1 at chr19_GL949746v1_alt:81433-90168 - (NM_013342.3)
TCF3 fusion partner, transcript variant 1 at chr19:54107013-54115675 - (NM_013342.3)
POM121 and ZP3 fusion, transcript variant 1 at chr7_KI270809v1_alt:96821-114138 - (NM_012230.3)
POM121 and ZP3 fusion, transcript variant 1 at chr7:76609986-76627303 - (NM_012230.3)
N-ethylmaleimide sensitive factor, vesicle fusing ATPase, transcript variant 1 at chr17_KI270908v1_alt:1110346-1276876 - (NM_006178.3)
N-ethylmaleimide sensitive factor, vesicle fusing ATPase, transcript variant 1 at chr17_GL000258v2_alt:1576739-1743341 - (NM_006178.3)
N-ethylmaleimide sensitive factor, vesicle fusing ATPase, transcript variant 1 at chr17:46590669-46757464 - (NM_006178.3)
FUS RNA binding protein, transcript variant 1 at chr16:31180110-31194871 - (NM_004960.3)
FAU, ubiquitin like and ribosomal protein S30 fusion at chr11:65120627-65122200 - (NM_001997.4)
izumo sperm-egg fusion 1, transcript variant 3 at chr19:48740888-48745932 - (NM_001321865.1)
TCF3 fusion partner, transcript variant 2 at chr19_KI270938v1_alt:81433-89567 - (NM_001321792.1)
TCF3 fusion partner, transcript variant 2 at chr19_GL949753v2_alt:81433-89567 - (NM_001321792.1)
TCF3 fusion partner, transcript variant 2 at chr19_GL949752v1_alt:81433-89567 - (NM_001321792.1)
TCF3 fusion partner, transcript variant 2 at chr19_GL949751v2_alt:81433-89567 - (NM_001321792.1)
TCF3 fusion partner, transcript variant 2 at chr19_GL949750v2_alt:81433-89567 - (NM_001321792.1)
TCF3 fusion partner, transcript variant 2 at chr19_GL949749v2_alt:81433-89567 - (NM_001321792.1)
TCF3 fusion partner, transcript variant 2 at chr19_GL949748v2_alt:81433-89567 - (NM_001321792.1)
TCF3 fusion partner, transcript variant 2 at chr19_GL949747v2_alt:81433-89567 - (NM_001321792.1)
TCF3 fusion partner, transcript variant 2 at chr19_GL949746v1_alt:81433-89567 - (NM_001321792.1)
TCF3 fusion partner, transcript variant 2 at chr19:54107013-54115074 - (NM_001321792.1)
ubiquitin A-52 residue ribosomal protein fusion product 1, transcript variant 7 at chr19:18572840-18577460 - (NM_001321021.1)
ubiquitin A-52 residue ribosomal protein fusion product 1, transcript variant 5 at chr19:18571874-18577460 - (NM_001321019.1)
ubiquitin A-52 residue ribosomal protein fusion product 1, transcript variant 3 at chr19:18571730-18577460 - (NM_001321017.1)
SET domain and mariner transposase fusion gene, transcript variant 6 at chr3:4303304-4317265 - (NM_001320677.1)
myomixer, myoblast fusion factor, transcript variant 1 at chr6:44216939-44218236 - (NM_001315494.1)
SET domain and mariner transposase fusion gene, transcript variant 2 at chr3:4303304-4317265 - (NM_001243723.1)
TRK-fused gene, transcript variant 3 at chr3:100709542-100748967 - (NM_001195478.1)
FUS RNA binding protein, transcript variant 3 at chr16:31180110-31194871 - (NM_001170634.1)
myomaker, myoblast fusion factor at chr9:133514586-133524946 - (NM_001080483.2)
TRK-fused gene, transcript variant 2 at chr3:100709290-100748967 - (NM_001007565.2)
ubiquitin A-52 residue ribosomal protein fusion product 1, transcript variant 1 at chr19:18571802-18577460 - (NM_001033930.2)
leukemia NUP98 fusion partner 1 at chr3:100401193-100456326 - (NM_001085451.1)
FUS RNA binding protein, transcript variant 4 at chr16:31180110-31194871 - (NM_001170937.1)
TRK-fused gene, transcript variant 4 at chr3:100709331-100748967 - (NM_001195479.1)
SET domain and mariner transposase fusion gene, transcript variant 4 at chr3:4303304-4314402 - (NM_001276325.1)
SET domain and mariner transposase fusion gene, transcript variant 5 at chr3:4303304-4317265 - (NM_001320676.1)
SET domain and mariner transposase fusion gene, transcript variant 7 at chr3:4303304-4317265 - (NM_001320678.1)
ubiquitin A-52 residue ribosomal protein fusion product 1, transcript variant 4 at chr19:18571874-18577460 - (NM_001321018.1)
ubiquitin A-52 residue ribosomal protein fusion product 1, transcript variant 6 at chr19:18571874-18577460 - (NM_001321020.1)
ubiquitin A-52 residue ribosomal protein fusion product 1, transcript variant 8 at chr19:18571802-18577460 - (NM_001321022.1)
izumo sperm-egg fusion 1, transcript variant 2 at chr19:48740888-48746909 - (NM_001321864.1)
myomixer, myoblast fusion factor, transcript variant 2 at chr6:44216962-44218236 - (NM_001347931.1)
ubiquitin A-52 residue ribosomal protein fusion product 1, transcript variant 2 at chr19:18571802-18577460 - (NM_003333.4)
TRK-fused gene, transcript variant 1 at chr3:100709331-100748967 - (NM_006070.5)
SET domain and mariner transposase fusion gene, transcript variant 1 at chr3:4303304-4317265 - (NM_006515.3)
rearranged L-myc fusion at chr1:40161369-40240921 - (NM_012421.3)
CHRNA7 (exons 5-10) and FAM7A (exons A-E) fusion, transcript variant 1 at chr15:30361240-30393661 - (NM_139320.1)
CHRNA7 (exons 5-10) and FAM7A (exons A-E) fusion, transcript variant 1 at chr15_KI270905v1_alt:2646214-2678539 - (NM_139320.1)
CHRNA7 (exons 5-10) and FAM7A (exons A-E) fusion, transcript variant 1 at chr15_KN538374v1_fix:2533730-2566055 - (NM_139320.1)
POM121 and ZP3 fusion, transcript variant 2 at chr7:76609986-76627303 - (NM_152992.2)
POM121 and ZP3 fusion, transcript variant 2 at chr7_KI270809v1_alt:96821-114138 - (NM_152992.2)
FUS RNA binding protein, transcript variant 2 at chr16:31180110-31194871 - (NR_028388.2)
DISC1 fusion partner 1 (non-protein coding) at chr11:90251232-90915052 - (NR_104190.1)

NCBI RefSeq genes, predicted subset (XM_* or XR_*)

FUS RNA binding protein, transcript variant X2 at chr16:31180139-31191605 - (XM_024450221.1)
myomixer, myoblast fusion factor, transcript variant X1 at chr6:44192365-44218236 - (XM_024446299.1)
TRK-fused gene, transcript variant X3 at chr3:100709710-100748964 - (XM_017005527.1)
rearranged L-myc fusion, transcript variant X2 at chr1:40161392-40240921 - (XM_017002017.2)
FUS RNA binding protein, transcript variant X4 at chr16:31184372-31191605 - (XM_011545782.2)
CHRNA7 (exons 5-10) and FAM7A (exons A-E) fusion, transcript variant X3 at chr15:30360566-30393656 - (XM_011522155.3)
TRK-fused gene, transcript variant X2 at chr3:100709970-100748964 - (XM_011512334.1)
TRK-fused gene, transcript variant X1 at chr3:100709710-100748964 - (XM_006713472.1)
SET domain and mariner transposase fusion gene, transcript variant X1 at chr3:4303561-4320649 - (XM_006713292.3)
ubiquitin A-52 residue ribosomal protein fusion product 1, transcript variant X5 at chr19:18563766-18575241 - (XM_005260054.2)
ubiquitin A-52 residue ribosomal protein fusion product 1, transcript variant X2 at chr19:18571858-18575241 - (XM_005260052.2)
CHRNA7 (exons 5-10) and FAM7A (exons A-E) fusion, transcript variant X2 at chr15:30360566-30393656 - (XM_005254750.3)
TRK-fused gene, transcript variant X4 at chr3:100709310-100748964 - (XM_005247066.2)
FUS RNA binding protein, transcript variant X3 at chr16:31180155-31191605 - (XM_005255233.5)
ubiquitin A-52 residue ribosomal protein fusion product 1, transcript variant X3 at chr19:18571804-18575241 - (XM_005260053.3)
TCF3 fusion partner, transcript variant X1 at chr19:54107020-54114601 - (XM_005278261.1)
SET domain and mariner transposase fusion gene, transcript variant X2 at chr3:4303583-4320649 - (XM_006713294.4)
ubiquitin A-52 residue ribosomal protein fusion product 1, transcript variant X4 at chr19:18571870-18575241 - (XM_006722871.2)
CHRNA7 (exons 5-10) and FAM7A (exons A-E) fusion, transcript variant X1 at chr15:30360566-30393849 - (XM_011522153.2)
FUS RNA binding protein, transcript variant X1 at chr16:31180138-31191605 - (XM_011545781.1)
rearranged L-myc fusion, transcript variant X1 at chr1:40161392-40240921 - (XM_017002016.2)
rearranged L-myc fusion, transcript variant X3 at chr1:40161397-40240921 - (XM_017002018.2)
ubiquitin A-52 residue ribosomal protein fusion product 1, transcript variant X1 at chr19:18571900-18575241 - (XM_017027198.1)
myomixer, myoblast fusion factor, transcript variant X2 at chr6:44204952-44218236 - (XM_024446300.1)
TCF3 fusion partner, transcript variant X2 at chr19:54107029-54115657 - (XR_935813.3)

NCBI RefSeq other annotations (not NM_*, NR_*, XM_*, XR_*, NP_* or YP_*)

SRSF10P2 at chr20:7831501-7832481
SRSF10P1 at chr18:51158202-51159443

Non-Human RefSeq Genes

FUS12 at chr15:49129471-49145078 - (NM_128257) proteasome family protein
FUS9 at chr3:23887565-23889237 - (NM_001035614) Ubiquitin-conjugating enzyme family protein
SUFU at chr10:102503949-102633454 - (NM_001372369) suppressor of fused homolog
PALM2AKAP2 at chr9:109780198-110172511 - (NM_001371506) PALM2-AKAP2 fusion isoform 2 (PALM2-AKAP2)
F19H22.30; F19H22_30 at chr18:26831970-26832329 - (NM_120053) Ubiquitin fusion degradation UFD1 family protein
F19H22.30; F19H22_30 at chr18:26831970-26832329 - (NM_001342513) Ubiquitin fusion degradation UFD1 family protein
F19H22.30; F19H22_30 at chr18:26831970-26832329 - (NM_202980) Ubiquitin fusion degradation UFD1 family protein
F19H22.30; F19H22_30 at chr18:26831970-26832329 - (NM_001342514) Ubiquitin fusion degradation UFD1 family protein
UFD1 at chr18:26831970-26832329 - (NM_127699) ubiquitin fusion degradation 1
nsf-1 at chr17_GL000258v2_alt:274423-325842 - (NM_001083135) Vesicle-fusing ATPase
nsf-1 at chr17_GL000258v2_alt:1629156-1714822 - (NM_001083135) Vesicle-fusing ATPase
nsf-1 at chr17:46643100-46728931 - (NM_001083135) Vesicle-fusing ATPase
nsf-1 at chr17:46425523-46476950 - (NM_001083135) Vesicle-fusing ATPase
nsf-1 at chr17_KI270908v1_alt:1162783-1248360 - (NM_001083135) Vesicle-fusing ATPase
nsf-1 at chr17:46425523-46476950 - (NM_001083134) Vesicle-fusing ATPase
nsf-1 at chr17_GL000258v2_alt:274423-325842 - (NM_001083134) Vesicle-fusing ATPase
nsf-1 at chr17_GL000258v2_alt:1629156-1714822 - (NM_001083134) Vesicle-fusing ATPase
nsf-1 at chr17:46643100-46728931 - (NM_001083134) Vesicle-fusing ATPase
nsf-1 at chr17_KI270908v1_alt:1162783-1248360 - (NM_001083134) Vesicle-fusing ATPase
IZUMO1 at chr19:48741789-48745841 - (NM_001164492) izumo sperm-egg fusion protein 1 precursor
IZUMO2 at chr19:50158269-50163236 - (NM_001318079) izumo sperm-egg fusion protein 2 precursor
Izumo2 at chr19:50152557-50163206 - (NM_029317) izumo sperm-egg fusion protein 2 isoform 1 precursor
Izumo2 at chr19:50152557-50163206 - (NM_001368390) izumo sperm-egg fusion protein 2 isoform 2 precursor
NSF at chr17_KI270908v1_alt:1110409-1276877 - (NM_001304614) vesicle-fusing ATPase
NSF at chr17_GL000258v2_alt:1576802-1743342 - (NM_001304614) vesicle-fusing ATPase
NSF at chr17:46590732-46757465 - (NM_001304614) vesicle-fusing ATPase
ECU02_1080 at chr12:124913544-124913771 - (NM_001040822) ubiquitin-40S ribosomal protein S31 fusion protein
ECU02_1080 at chr12:124913316-124913543 - (NM_001040822) ubiquitin-40S ribosomal protein S31 fusion protein
ECU02_1080 at chr12:124912860-124913087 - (NM_001040822) ubiquitin-40S ribosomal protein S31 fusion protein
ECU02_1080 at chr12:124912404-124912631 - (NM_001040822) ubiquitin-40S ribosomal protein S31 fusion protein
Fus at chr16:31180133-31191602 - (NM_139149) RNA-binding protein FUS isoform 1
Fus at chr16:31180133-31191602 - (NM_001347649) RNA-binding protein FUS isoform 2
Nsf at chr17_KI270908v1_alt:1143920-1275866 - (NM_021748) vesicle-fusing ATPase
Nsf at chr17_GL000258v2_alt:1610279-1741771 - (NM_021748) vesicle-fusing ATPase
Nsf at chr17:46624247-46756455 - (NM_021748) vesicle-fusing ATPase
sufu at chr10:102504229-102630155 - (NM_201309) suppressor of fused homolog
nsfa at chr17_KI270908v1_alt:1143920-1271026 - (NM_001044328) vesicle-fusing ATPase
nsfa at chr17_GL000258v2_alt:1610279-1737492 - (NM_001044328) vesicle-fusing ATPase
nsfa at chr17:46406667-46751616 - (NM_001044328) vesicle-fusing ATPase
Nsf at chr17_KI270908v1_alt:1110404-1276873 - (NM_008740) vesicle-fusing ATPase
Nsf at chr17_GL000258v2_alt:1576797-1743338 - (NM_008740) vesicle-fusing ATPase
Nsf at chr17:46590727-46757462 - (NM_008740) vesicle-fusing ATPase
NSF at chr17_KI270908v1_alt:1110404-1276874 - (NM_001133578) vesicle-fusing ATPase
NSF at chr17:46590727-46757462 - (NM_001133578) vesicle-fusing ATPase
NSF at chr17_GL000258v2_alt:1576797-1743339 - (NM_001133578) vesicle-fusing ATPase
Izumo1 at chr19:48741790-48746697 - (NM_001018013) izumo sperm-egg fusion protein 1 precursor
TFPT at chr19_GL949746v1_alt:81465-89789 - (NM_001075274) TCF3 fusion partner homolog
TFPT at chr19_GL949749v2_alt:81465-89789 - (NM_001075274) TCF3 fusion partner homolog
TFPT at chr19_GL949748v2_alt:81465-89789 - (NM_001075274) TCF3 fusion partner homolog
TFPT at chr19_GL949750v2_alt:81465-89789 - (NM_001075274) TCF3 fusion partner homolog
TFPT at chr19_GL949751v2_alt:81465-89789 - (NM_001075274) TCF3 fusion partner homolog
TFPT at chr19_GL949752v1_alt:81465-89789 - (NM_001075274) TCF3 fusion partner homolog
TFPT at chr19_GL949753v2_alt:81465-89789 - (NM_001075274) TCF3 fusion partner homolog
TFPT at chr19_KI270938v1_alt:81470-89789 - (NM_001075274) TCF3 fusion partner homolog
TFPT at chr19_GL949747v2_alt:81465-89789 - (NM_001075274) TCF3 fusion partner homolog
TFPT at chr19:54107050-54115296 - (NM_001075274) TCF3 fusion partner homolog
Tfpt at chr19_GL949747v2_alt:81470-89189 - (NM_138870) TCF3 fusion partner homolog
Tfpt at chr19_GL949752v1_alt:81470-89189 - (NM_138870) TCF3 fusion partner homolog
Tfpt at chr19_GL949751v2_alt:81470-89189 - (NM_138870) TCF3 fusion partner homolog
Tfpt at chr19_KI270938v1_alt:81470-89189 - (NM_138870) TCF3 fusion partner homolog
Tfpt at chr19_GL949749v2_alt:81470-89189 - (NM_138870) TCF3 fusion partner homolog
Tfpt at chr19_GL949748v2_alt:81470-89189 - (NM_138870) TCF3 fusion partner homolog
Tfpt at chr19:54107050-54114696 - (NM_138870) TCF3 fusion partner homolog
Tfpt at chr19_GL949746v1_alt:81470-89189 - (NM_138870) TCF3 fusion partner homolog
Tfpt at chr19_GL949753v2_alt:81470-89189 - (NM_138870) TCF3 fusion partner homolog
Tfpt at chr19_GL949750v2_alt:81470-89189 - (NM_138870) TCF3 fusion partner homolog
Izumo1 at chr19:48741790-48745926 - (NM_001017514) izumo sperm-egg fusion protein 1 precursor
Mon1a at chr3:49908891-49929781 - (NM_028369) vacuolar fusion protein MON1 homolog A
MON1A at chr3:49908866-49929692 - (NM_001015623) vacuolar fusion protein MON1 homolog A
ccz1b.S at chr7:6799224-6826134 - (NM_001086853) vacuolar fusion protein CCZ1 homolog
ccz1b.S at chr7:5898839-5925806 - (NM_001086853) vacuolar fusion protein CCZ1 homolog
Ccz1 at chr7:5898835-5925976 - (NM_177682) vacuolar fusion protein CCZ1 homolog
Ccz1 at chr7:6798936-6826156 - (NM_177682) vacuolar fusion protein CCZ1 homolog
ccz1 at chr7:6799221-6826152 - (NM_200134) vacuolar fusion protein CCZ1 homolog
ccz1 at chr7:5898845-5925690 - (NM_200134) vacuolar fusion protein CCZ1 homolog
CCZ1 at chr7:5898711-5925971 - (NM_001075492) vacuolar fusion protein CCZ1 homolog
CCZ1 at chr7:6798940-6826278 - (NM_001075492) vacuolar fusion protein CCZ1 homolog
ccz1b at chr7:6799224-6826152 - (NM_001008197) vacuolar fusion protein CCZ1 homolog
ccz1b at chr7:5898839-5925806 - (NM_001008197) vacuolar fusion protein CCZ1 homolog
fus at chr16:31185139-31191117 - (NM_201083) RNA-binding protein FUS
Mon1b at chr16:77191475-77198308 - (NM_001048143) vacuolar fusion protein MON1 homolog B
Sufu at chr10:102503942-102633457 - (NM_001025391) suppressor of fused homolog isoform 2
Mon1b at chr16:77191434-77198308 - (NM_173015) vacuolar fusion protein MON1 homolog B
Sufu at chr10:102503942-102633457 - (NM_015752) suppressor of fused homolog isoform 1
Izumo3 at chr9:24543269-24545784 - (NM_027034) izumo sperm-egg fusion protein 3 precursor
IZUMO3 at chr9:24543256-24545880 - (NM_001105642) izumo sperm-egg fusion protein 3 precursor
Izumo1r at chr11:94306503-94307300 - (NM_176807) sperm-egg fusion protein Juno isoform 2 precursor
Izumo1r at chr11:94306503-94307690 - (NM_022888) sperm-egg fusion protein Juno isoform 1 precursor
Izumo4 at chr19:2096976-2099353 - (NM_027829) izumo sperm-egg fusion protein 4 precursor
CCZ1 at chr7:6799107-6826288 - (NM_001006158) vacuolar fusion protein CCZ1 homolog
CCZ1 at chr7:5898839-5925946 - (NM_001006158) vacuolar fusion protein CCZ1 homolog
Ufd1-like at chr22:19458068-19471806 - (NM_079299) ubiquitin fusion-degradation 1-like
Ufd4 at chr14:31100930-31205936 - (NM_135525) ubiquitin fusion-degradation 4-like
FUS at chr16:31180159-31191603 - (NM_173912) RNA-binding protein FUS
Tfpt at chr19_KI270938v1_alt:81470-90073 - (NM_023524) TCF3 fusion partner homolog isoform 2
Tfpt at chr19_GL949753v2_alt:81468-90161 - (NM_023524) TCF3 fusion partner homolog isoform 2
Tfpt at chr19_GL949752v1_alt:81468-90161 - (NM_023524) TCF3 fusion partner homolog isoform 2
Tfpt at chr19_GL949751v2_alt:81468-90161 - (NM_023524) TCF3 fusion partner homolog isoform 2
Tfpt at chr19_GL949750v2_alt:81468-90161 - (NM_023524) TCF3 fusion partner homolog isoform 2
Tfpt at chr19_GL949749v2_alt:81470-89765 - (NM_023524) TCF3 fusion partner homolog isoform 2
Tfpt at chr19_GL949748v2_alt:81468-90161 - (NM_023524) TCF3 fusion partner homolog isoform 2
Tfpt at chr19_GL949747v2_alt:81468-90161 - (NM_023524) TCF3 fusion partner homolog isoform 2
Tfpt at chr19_GL949746v1_alt:81470-90161 - (NM_023524) TCF3 fusion partner homolog isoform 2
Tfpt at chr19:54107050-54115580 - (NM_023524) TCF3 fusion partner homolog isoform 2
Tfpt at chr19_GL949747v2_alt:81468-90161 - (NM_001290381) TCF3 fusion partner homolog isoform 1
Tfpt at chr19_GL949746v1_alt:81470-90161 - (NM_001290381) TCF3 fusion partner homolog isoform 1
Tfpt at chr19:54107050-54115580 - (NM_001290381) TCF3 fusion partner homolog isoform 1
Tfpt at chr19_KI270938v1_alt:81470-90073 - (NM_001290381) TCF3 fusion partner homolog isoform 1
Tfpt at chr19_GL949753v2_alt:81468-90161 - (NM_001290381) TCF3 fusion partner homolog isoform 1
Tfpt at chr19_GL949752v1_alt:81468-90161 - (NM_001290381) TCF3 fusion partner homolog isoform 1
Tfpt at chr19_GL949751v2_alt:81468-90161 - (NM_001290381) TCF3 fusion partner homolog isoform 1
Tfpt at chr19_GL949750v2_alt:81468-90161 - (NM_001290381) TCF3 fusion partner homolog isoform 1
Tfpt at chr19_GL949749v2_alt:81470-89765 - (NM_001290381) TCF3 fusion partner homolog isoform 1
Tfpt at chr19_GL949748v2_alt:81468-90161 - (NM_001290381) TCF3 fusion partner homolog isoform 1
Nsf at chr17:46406667-46728931 - (NM_001159913) vesicle-fusing ATPase
Nsf at chr17_GL000258v2_alt:1610279-1714822 - (NM_001159913) vesicle-fusing ATPase
Nsf at chr17_KI270908v1_alt:1143920-1248360 - (NM_001159913) vesicle-fusing ATPase
Nsf at chr17_GL000258v2_alt:274414-345034 - (NM_001159913) vesicle-fusing ATPase
MON1A at chr3:49909014-49912012 - (NM_001030587) vacuolar fusion protein MON1 homolog A
MON1B at chr16:77191197-77198755 - (NM_001284622) vacuolar fusion protein MON1 homolog B
LNP1 at chr3:100429691-100456369 - (NM_001205535) leukemia NUP98 fusion partner 1
Mon1a at chr3:49908876-49929763 - (NM_001126284) vacuolar fusion protein MON1 homolog A
Sufu at chr10:102503994-102630191 - (NM_001024899) suppressor of fused homolog
Ccz1b at chr7:6799020-6826275 - (NM_001014126) vacuolar fusion protein CCZ1 homolog
Ccz1b at chr7:5898835-5925969 - (NM_001014126) vacuolar fusion protein CCZ1 homolog
Fus at chr16:31180172-31191587 - (NM_001012137) RNA-binding protein FUS
Lnp1 at chr3:100429763-100451946 - (NM_001347042) leukemia NUP98 fusion partner 1
FUS at chr16:31182511-31191438 - (NM_001001531) RNA-binding protein FUS
NSF at chr17_KI270908v1_alt:1143920-1274778 - (NM_001024456) vesicle-fusing ATPase
NSF at chr17_GL000258v2_alt:1610279-1741244 - (NM_001024456) vesicle-fusing ATPase
NSF at chr17:46624247-46755367 - (NM_001024456) vesicle-fusing ATPase
SUFU at chr10:102504228-102630155 - (NM_204264) suppressor of fused homolog
IZUMO4 at chr19:2096973-2099345 - (NM_001101928) izumo sperm-egg fusion protein 4
SUFU at chr10:102504036-102624451 - (NM_001098083) suppressor of fused homolog
MON1B at chr16:77191312-77201549 - (NM_001037454) vacuolar fusion protein MON1 homolog B
IZUMO2 at chr19:50074261-50163021 - (NM_001110097) izumo sperm-egg fusion protein 2
RPS31 at chr12:124911720-124911947 - (NM_001182054) ubiquitin-ribosomal 40S subunit protein S31 fusion protein
RPS31 at chr2:55232825-55234965 - (NM_001182054) ubiquitin-ribosomal 40S subunit protein S31 fusion protein
RPL40B at chr12:124912632-124912859 - (NM_001179884) ubiquitin-ribosomal 60S subunit protein L40B fusion protein
RPL40B at chr12:124911948-124912175 - (NM_001179884) ubiquitin-ribosomal 60S subunit protein L40B fusion protein
RPL40B at chr12:124912176-124912403 - (NM_001179884) ubiquitin-ribosomal 60S subunit protein L40B fusion protein
RPL40A at chr12:124911720-124911947 - (NM_001179496) ubiquitin-ribosomal 60S subunit protein L40A fusion protein
RPL40A at chr12:124911948-124912175 - (NM_001179496) ubiquitin-ribosomal 60S subunit protein L40A fusion protein
RPL40A at chr12:124912176-124912403 - (NM_001179496) ubiquitin-ribosomal 60S subunit protein L40A fusion protein
RPL40A at chr12:124912632-124912859 - (NM_001179496) ubiquitin-ribosomal 60S subunit protein L40A fusion protein
FUS3 at chr17:19379790-19380911 - (NM_001178256) mitogen-activated serine/threonine-protein kinase FUS3
FUS3 at chr16:30118050-30121975 - (NM_001178256) mitogen-activated serine/threonine-protein kinase FUS3
uep1 at chr12:124913088-124913315 - (NM_001019352) ubiquitin-60S ribosomal protein L40 fusion protein
SPAC589.10c at chr2:55232819-55235472 - (NM_001019482) ubiquitin-40S ribosomal protein S31 fusion protein
SPAC589.10c at chr1:192716177-192716506 - (NM_001019482) ubiquitin-40S ribosomal protein S31 fusion protein
ubi1 at chrX:3717150-3717374 - (NM_001019821) ubiquitin-60S ribosomal protein L40 fusion protein
ubi1 at chr2:55232819-55234869 - (NM_001019821) ubiquitin-60S ribosomal protein L40 fusion protein
ubi1 at chr19:18573301-18575162 - (NM_001019821) ubiquitin-60S ribosomal protein L40 fusion protein
ubi1 at chr17:16382136-16382363 - (NM_001019821) ubiquitin-60S ribosomal protein L40 fusion protein
ubi1 at chr17:16381908-16382135 - (NM_001019821) ubiquitin-60S ribosomal protein L40 fusion protein
ubi1 at chr12:124913544-124913771 - (NM_001019821) ubiquitin-60S ribosomal protein L40 fusion protein
ubi3 at chr2:55232825-55235472 - (NM_001019532) ubiquitin-40S ribosomal protein S31 fusion protein
FUS at chr16:31180205-31191604 - (NM_001328286) RNA-binding protein FUS
TFPT at chr19_KI270938v1_alt:81468-89762 - (NM_001361491) TCF3 fusion partner
TFPT at chr19_GL949753v2_alt:81468-89762 - (NM_001361491) TCF3 fusion partner
TFPT at chr19_GL949752v1_alt:81468-89762 - (NM_001361491) TCF3 fusion partner
TFPT at chr19_GL949751v2_alt:81468-89762 - (NM_001361491) TCF3 fusion partner
TFPT at chr19_GL949750v2_alt:81468-89762 - (NM_001361491) TCF3 fusion partner
TFPT at chr19_GL949749v2_alt:81468-89194 - (NM_001361491) TCF3 fusion partner
TFPT at chr19_GL949748v2_alt:81468-89762 - (NM_001361491) TCF3 fusion partner
TFPT at chr19_GL949747v2_alt:81468-89762 - (NM_001361491) TCF3 fusion partner
TFPT at chr19_GL949746v1_alt:81468-89762 - (NM_001361491) TCF3 fusion partner
TFPT at chr19:54107048-54115269 - (NM_001361491) TCF3 fusion partner
Mon1b at chr16:77191434-77198308 - (NM_001107433) vacuolar fusion protein MON1 homolog B
fubp1.L at chr1:77948403-77979004 - (NM_001096749) far upstream element (FUSE) binding protein 1 L homeolog isoform 1
fubp1.L at chr1:77948372-77979004 - (NM_001097060) far upstream element (FUSE) binding protein 1 L homeolog isoform 2
LOC100193565 at chr17_KI270908v1_alt:1162837-1248360 - (NM_001358831) Vesicle-fusing ATPase
LOC100193565 at chr17_GL000258v2_alt:1629210-1714822 - (NM_001358831) Vesicle-fusing ATPase
LOC100193565 at chr17:46643154-46728931 - (NM_001358831) Vesicle-fusing ATPase
Lhfpl2 at chr5:78485358-78564871 - (NM_001106402) lipoma HMGIC fusion partner-like 2 protein
AGOS_AGL128W at chr12:124911720-124911947 - (NM_211601) ubiquitin-40S ribosomal protein S31 fusion protein
AGOS_AFR285C at chr12:124911720-124911947 - (NM_211187) ubiquitin-60S ribosomal protein L40 fusion protein
lhfpl6 at chr13:39343936-39601216 - (NM_001127145) lipoma HMGIC fusion partner precursor
ftz-f1 at chr9:124482768-124503395 - (NM_001124537) fushi tarazu factor 1
lhfpl3 at chr7:104328822-104736910 - (NM_001345945) lipoma HMGIC fusion partner-like 3 protein isoform 2
lhfpl4 at chr3:9505968-9552679 - (NM_001102981) lipoma HMGIC fusion partner-like 4 protein
lhfpl3 at chr7:104328822-104736910 - (NM_001126783) lipoma HMGIC fusion partner-like 3 protein isoform 1
TFPT at chr19_KI270938v1_alt:81470-89762 - (NM_001168872) TCF3 fusion partner
TFPT at chr19_GL949753v2_alt:81470-89762 - (NM_001168872) TCF3 fusion partner
TFPT at chr19_GL949752v1_alt:81470-89762 - (NM_001168872) TCF3 fusion partner
TFPT at chr19_GL949751v2_alt:81470-89762 - (NM_001168872) TCF3 fusion partner
TFPT at chr19_GL949750v2_alt:81470-89762 - (NM_001168872) TCF3 fusion partner
TFPT at chr19_GL949749v2_alt:81470-89194 - (NM_001168872) TCF3 fusion partner
TFPT at chr19_GL949748v2_alt:81470-89762 - (NM_001168872) TCF3 fusion partner
TFPT at chr19_GL949747v2_alt:81470-89762 - (NM_001168872) TCF3 fusion partner
TFPT at chr19_GL949746v1_alt:81470-89762 - (NM_001168872) TCF3 fusion partner
TFPT at chr19:54107050-54115269 - (NM_001168872) TCF3 fusion partner
lhfpl2b at chr5:78488897-78510213 - (NM_001017562) lipoma HMGIC fusion partner-like 2 protein
TFPT at chr19:54106809-54115645 - (NM_001194720) TCF3 fusion partner
TFPT at chr19_GL949746v1_alt:81229-90138 - (NM_001194720) TCF3 fusion partner
TFPT at chr19_GL949747v2_alt:81229-90138 - (NM_001194720) TCF3 fusion partner
TFPT at chr19_GL949749v2_alt:81229-90138 - (NM_001194720) TCF3 fusion partner
TFPT at chr19_GL949748v2_alt:81229-90138 - (NM_001194720) TCF3 fusion partner
TFPT at chr19_GL949750v2_alt:81229-90138 - (NM_001194720) TCF3 fusion partner
TFPT at chr19_GL949751v2_alt:81229-90138 - (NM_001194720) TCF3 fusion partner
TFPT at chr19_GL949752v1_alt:81229-90138 - (NM_001194720) TCF3 fusion partner
TFPT at chr19_KI270938v1_alt:81229-90137 - (NM_001194720) TCF3 fusion partner
TFPT at chr19_GL949753v2_alt:81229-90138 - (NM_001194720) TCF3 fusion partner
LHFPL6 at chr13:39342895-39603180 - (NM_001284530) lipoma HMGIC fusion partner precursor
LHFPL2 at chr5:78487684-78648587 - (NM_001243213) lipoma HMGIC fusion partner-like 2 protein
IZUMO4 at chr19:2096865-2099587 - (NM_001194062) izumo sperm-egg fusion protein 4 precursor
lhfp at chr13:39343936-39601222 - (NM_001200901) lipoma HMGIC fusion partner homolog precursor
LOC692779 at chr19:18573301-18575147 - (NM_001043907) ubiquitin/ribosomal protein L40 fusion protein
LOC692779 at chr17:16381908-16382135 - (NM_001043907) ubiquitin/ribosomal protein L40 fusion protein
IZUMO4 at chr19:2096895-2099581 - (NM_001287690) izumo sperm-egg fusion protein 4 precursor
Nsf at chr17_KI270908v1_alt:1110424-1276872 - (NM_001310283) vesicle-fusing ATPase
Nsf at chr17_GL000258v2_alt:1576817-1743337 - (NM_001310283) vesicle-fusing ATPase
Nsf at chr17:46590747-46757460 - (NM_001310283) vesicle-fusing ATPase
NSF at chr17_KI270908v1_alt:1110433-1275400 - (NM_001244560) vesicle-fusing ATPase
NSF at chr17_GL000258v2_alt:1610276-1741865 - (NM_001244560) vesicle-fusing ATPase
NSF at chr17:46590755-46755988 - (NM_001244560) vesicle-fusing ATPase
ufd1.S at chr22:19450670-19475602 - (NM_001090169) ubiquitin fusion degradation protein 1 homolog
ufd1 at chr22:19450670-19475602 - (NM_001006805) ubiquitin fusion degradation protein 1 homolog
fus at chr16:31183857-31191117 - (NM_001097367) RNA-binding protein FUS
ufd1 at chr22:19450670-19475602 - (NM_001292478) ubiquitin fusion degradation protein 1 homolog
MON1A at chr3:49908869-49929756 - (NM_001243701) vacuolar fusion protein MON1 homolog A
tfg.L at chr3:100713677-100748531 - (NM_001092392) trk-fused a
tfg.S at chr3:100713677-100748531 - (NM_001086952) trk-fused b
CHRFAM7A at chr15:32030899-32168458 - (NM_001323297) CHRNA7-FAM7A fusion protein
CHRFAM7A at chr15_KN538374v1_fix:4203567-4341343 - (NM_001323297) CHRNA7-FAM7A fusion protein
CHRFAM7A at chr15_KI270905v1_alt:4316019-4453795 - (NM_001323297) CHRNA7-FAM7A fusion protein
CHRFAM7A at chr15_KQ031389v1_alt:359625-497392 - (NM_001323297) CHRNA7-FAM7A fusion protein
LOC101264240 at chr12:124913544-124913772 - (NM_001330775) ubiquitin-ribosomal fusion protein
SUFU at chr10:102503972-102630264 - (NM_001287734) suppressor of fused homolog
nsf.L at chr17_KI270908v1_alt:1143917-1274781 - (NM_001098679) vesicle-fusing ATPase
nsf.L at chr17_GL000258v2_alt:1610276-1737492 - (NM_001098679) vesicle-fusing ATPase
nsf.L at chr17:46624244-46755370 - (NM_001098679) vesicle-fusing ATPase
setmar at chr3:4313186-4313533 - (NM_001114263) SET domain and mariner transposase fusion
tfpt at chr19_GL949749v2_alt:82746-89189 - (NM_001011268) TCF3 fusion partner
nsf at chr17_KI270908v1_alt:1143917-1274781 - (NM_001079320) vesicle-fusing ATPase
nsf at chr17_GL000258v2_alt:1610276-1741247 - (NM_001079320) vesicle-fusing ATPase
nsf at chr17:46624244-46755370 - (NM_001079320) vesicle-fusing ATPase
fus.S at chr16:31183923-31191117 - (NM_001086914) FUS RNA binding protein S homeolog
uba52.L at chr19:18573301-18575151 - (NM_001091987) ubiquitin A-52 residue ribosomal protein fusion product 1 L homeolog
RGD1562196 at chr19:18573298-18575151 - (NM_001346365) similar to ubiquitin A-52 residue ribosomal protein fusion product 1
IZUMO1 at chr19:48741789-48745841 - (NM_001287235) izumo sperm-egg fusion protein 1 precursor
SUFU at chr10:102503984-102633452 - (NM_001261066) suppressor of fused homolog
CCZ1B at chr7:6798939-6826264 - (NM_001280309) vacuolar fusion protein CCZ1 homolog B
CCZ1B at chr7:5898733-5925972 - (NM_001280309) vacuolar fusion protein CCZ1 homolog B
LNP1 at chr3:100401606-100456213 - (NM_001280233) leukemia NUP98 fusion partner 1
LOC100165847 at chr18:74389884-74390084 - (NM_001162751) ubiquitin/ribosomal protein S30e fusion protein-like
Ufd1l at chr22:19458068-19471806 - (NM_001204958) ubiquitin fusion degradation protein 1 homolog
FUS at chr16:31180143-31191550 - (NM_001284854) RNA-binding protein FUS
lhpl4 at chr3:9505989-9552622 - (NM_001146670) Lipoma HMGIC fusion partner-like 4 protein
LOC100194659 at chr19:18573296-18575150 - (NM_001139743) ubiquitin A-52 residue ribosomal protein fusion product 1like 2
nsf at chr17_KI270908v1_alt:1143920-1271026 - (NM_001139843) vesicle-fusing ATPase
nsf at chr17_GL000258v2_alt:1610279-1737492 - (NM_001139843) vesicle-fusing ATPase
nsf at chr17_GL000258v2_alt:274414-345034 - (NM_001139843) vesicle-fusing ATPase
nsf at chr17:46624247-46751616 - (NM_001139843) vesicle-fusing ATPase
nsf at chr17:46406667-46476959 - (NM_001139843) vesicle-fusing ATPase
IZUMO1 at chr19:48740908-48745859 - (NM_001194623) izumo sperm-egg fusion protein 1 precursor
IZUMO2 at chr19:50152566-50163194 - (NM_001194696) izumo sperm-egg fusion protein 2 precursor
IZUMO1R at chr11:94305637-94307692 - (NM_001193805) sperm-egg fusion protein Juno precursor
uba52 at chr17:22204321-22204548 - (NM_001292943) ubiquitin A-52 residue ribosomal protein fusion product 1
uba52 at chr17:16382364-16382591 - (NM_001292943) ubiquitin A-52 residue ribosomal protein fusion product 1
uba52 at chr17:16381908-16382135 - (NM_001292943) ubiquitin A-52 residue ribosomal protein fusion product 1
uba52 at chr19:18573295-18575150 - (NM_001292943) ubiquitin A-52 residue ribosomal protein fusion product 1
FUS at chr16:31182396-31191438 - (NM_001287420) RNA-binding protein FUS
NSF at chr17:46643130-46749835 - (NM_214587) vesicle-fusing ATPase
NSF at chr17_GL000258v2_alt:1629186-1737483 - (NM_214587) vesicle-fusing ATPase
NSF at chr17_KI270908v1_alt:1162813-1271017 - (NM_214587) vesicle-fusing ATPase

Basic Gene Annotation Set from GENCODE Version 31 (Ensembl 97)

FUS at chr16:31180110-31194871
FUS at chr16:31180139-31191602
FUS at chr16:31180151-31191575

Comprehensive Gene Annotation Set from GENCODE Version 31 (Ensembl 97)

FUS at chr16:31180110-31194871
FUS at chr16:31180138-31191602
FUS at chr16:31180139-31183350
FUS at chr16:31180139-31191602
FUS at chr16:31180150-31191602
FUS at chr16:31180151-31191575
FUS at chr16:31183550-31184398
FUS at chr16:31185080-31187245
FUS at chr16:31185499-31191102
FUS at chr16:31188152-31190120
FUS at chr16:31188467-31189695
FUS at chr16:31190216-31191605
FUS at chr16:31190373-31191558

Basic Gene Annotation Set from GENCODE Version 29 (Ensembl 94)

FUS at chr16:31180110-31194871
FUS at chr16:31180139-31191602
FUS at chr16:31180151-31191575

Comprehensive Gene Annotation Set from GENCODE Version 29 (Ensembl 94)

FUS at chr16:31180110-31194871
FUS at chr16:31180138-31191602
FUS at chr16:31180139-31183350
FUS at chr16:31180139-31191602
FUS at chr16:31180150-31191602
FUS at chr16:31180151-31191575
FUS at chr16:31183550-31184398
FUS at chr16:31185080-31187245
FUS at chr16:31185499-31191102
FUS at chr16:31188152-31190120
FUS at chr16:31188467-31189695
FUS at chr16:31190216-31191605
FUS at chr16:31190373-31191558

Basic Gene Annotation Set from GENCODE Version 28 (Ensembl 92)

FUS at chr16:31180110-31194871
FUS at chr16:31180139-31191602
FUS at chr16:31180151-31191575

Comprehensive Gene Annotation Set from GENCODE Version 28 (Ensembl 92)

FUS at chr16:31180110-31194871
FUS at chr16:31180138-31191602
FUS at chr16:31180139-31183350
FUS at chr16:31180139-31191602
FUS at chr16:31180150-31191602
FUS at chr16:31180151-31191575
FUS at chr16:31183550-31184398
FUS at chr16:31185080-31187245
FUS at chr16:31185499-31191102
FUS at chr16:31188152-31190120
FUS at chr16:31188467-31189695
FUS at chr16:31190216-31191605
FUS at chr16:31190373-31191558

Basic Gene Annotation Set from GENCODE Version 27 (Ensembl 90)

FUS at chr16:31180110-31194871
FUS at chr16:31180139-31191602
FUS at chr16:31180151-31191575

Comprehensive Gene Annotation Set from GENCODE Version 27 (Ensembl 90)

FUS at chr16:31180110-31194871
FUS at chr16:31180138-31191602
FUS at chr16:31180139-31183350
FUS at chr16:31180139-31191602
FUS at chr16:31180150-31191602
FUS at chr16:31180151-31191575
FUS at chr16:31183550-31184398
FUS at chr16:31185080-31187245
FUS at chr16:31185499-31191102
FUS at chr16:31188152-31190120
FUS at chr16:31188467-31189695
FUS at chr16:31190216-31191605
FUS at chr16:31190373-31191558

Basic Gene Annotation Set from GENCODE Version 26 (Ensembl 88)

FUS at chr16:31180110-31194871
FUS at chr16:31180139-31191602
FUS at chr16:31180151-31191575

Comprehensive Gene Annotation Set from GENCODE Version 26 (Ensembl 88)

FUS at chr16:31180110-31194871
FUS at chr16:31180138-31191602
FUS at chr16:31180139-31183350
FUS at chr16:31180139-31191602
FUS at chr16:31180150-31191602
FUS at chr16:31180151-31191575
FUS at chr16:31183550-31184398
FUS at chr16:31185080-31187245
FUS at chr16:31185499-31191102
FUS at chr16:31188152-31190120
FUS at chr16:31188467-31189695
FUS at chr16:31190216-31191605
FUS at chr16:31190373-31191558

Basic Gene Annotation Set from GENCODE Version 25 (Ensembl 85)

FUS at chr16:31180110-31194871
FUS at chr16:31180139-31191602
FUS at chr16:31180151-31191575

Comprehensive Gene Annotation Set from GENCODE Version 25 (Ensembl 85)

FUS at chr16:31180110-31194871
FUS at chr16:31180138-31191602
FUS at chr16:31180139-31183350
FUS at chr16:31180139-31191602
FUS at chr16:31180150-31191602
FUS at chr16:31180151-31191575
FUS at chr16:31183550-31184398
FUS at chr16:31185080-31187245
FUS at chr16:31185499-31191102
FUS at chr16:31188152-31190120
FUS at chr16:31188467-31189695
FUS at chr16:31190216-31191605
FUS at chr16:31190373-31191558

Basic Gene Annotation Set from GENCODE Version 24 (Ensembl 83)

FUS at chr16:31180110-31194871
FUS at chr16:31180139-31191602
FUS at chr16:31180151-31191575

Comprehensive Gene Annotation Set from GENCODE Version 24 (Ensembl 83)

FUS at chr16:31180110-31194871
FUS at chr16:31180138-31191602
FUS at chr16:31180139-31183350
FUS at chr16:31180139-31191602
FUS at chr16:31180150-31191602
FUS at chr16:31180151-31191575
FUS at chr16:31183550-31184398
FUS at chr16:31185080-31187245
FUS at chr16:31185499-31191102
FUS at chr16:31188152-31190120
FUS at chr16:31188467-31189695
FUS at chr16:31190216-31191605
FUS at chr16:31190373-31191558

Basic Gene Annotation Set from GENCODE Version 23 (Ensembl 81)

FUS at chr16:31180110-31194871
FUS at chr16:31180139-31191602
FUS at chr16:31180151-31191575

Comprehensive Gene Annotation Set from GENCODE Version 23 (Ensembl 81)

FUS at chr16:31180110-31194871
FUS at chr16:31180138-31191602
FUS at chr16:31180139-31183350
FUS at chr16:31180139-31191602
FUS at chr16:31180150-31191602
FUS at chr16:31180151-31191575
FUS at chr16:31183550-31184398
FUS at chr16:31185080-31187245
FUS at chr16:31185499-31191102
FUS at chr16:31188152-31190120
FUS at chr16:31188467-31189695
FUS at chr16:31190216-31191605
FUS at chr16:31190373-31191558

Basic Gene Annotation Set from GENCODE Version 22 (Ensembl 79)

FUS at chr16:31180110-31194871
FUS at chr16:31180139-31191602
FUS at chr16:31180151-31191575

Comprehensive Gene Annotation Set from GENCODE Version 22 (Ensembl 79)

FUS at chr16:31180110-31194871
FUS at chr16:31180138-31191602
FUS at chr16:31180139-31183350
FUS at chr16:31180139-31191602
FUS at chr16:31180150-31191602
FUS at chr16:31180151-31191575
FUS at chr16:31183550-31184398
FUS at chr16:31185080-31187245
FUS at chr16:31185499-31191102
FUS at chr16:31188152-31190120
FUS at chr16:31188467-31189695
FUS at chr16:31190216-31191605
FUS at chr16:31190373-31191558

Basic Gene Annotation Set from GENCODE Version 20 (Ensembl 76)

FUS at chr16:31180110-31194871
FUS at chr16:31180139-31191602
FUS at chr16:31180151-31191575

Comprehensive Gene Annotation Set from GENCODE Version 20 (Ensembl 76)

FUS at chr16:31180110-31194871
FUS at chr16:31180138-31191602
FUS at chr16:31180139-31183350
FUS at chr16:31180139-31191602
FUS at chr16:31180150-31191602
FUS at chr16:31180151-31191575
FUS at chr16:31183550-31184398
FUS at chr16:31185080-31187245
FUS at chr16:31185499-31191102
FUS at chr16:31188152-31190120
FUS at chr16:31188467-31189695
FUS at chr16:31190216-31191605
FUS at chr16:31190373-31191558

International Knockout Mouse Consortium Genes Mapped to Human Genome

Fus_103071 at chr16:31180110-31194871
Fus_103072 at chr16:31180110-31194871
Fus_114614 at chr16:31180110-31194871
Fus_65634 at chr16:31180110-31194871
Fus_69500 at chr16:31180110-31194871
Fus_80544 at chr16:31180110-31194871
Fus_84575 at chr16:31180110-31194871
Fus_VG11866 at chr16:31180110-31194871

MN037411 Alignments in Human Aligned mRNAs

This aligns in multiple positions. Click on a hyperlink to go to tracks display at a particular alignment.
 SIZE IDENTITY CHROMOSOME STRAND  START     END       cDNA   START  END  TOTAL
------------------------------------------------------------------------------
 1159  100.0%         19     -  50882096  50909414  MN037411     1  1159  1180

Non-Human Aligned mRNA Search Results

MK803127 - Bos grunniens breed Datong Izumo sperm egg fusion 1 (IZUMO1) mRNA, complete cds.
LC426749 - Mus musculus C57BL/6 Izumo1 mRNA for Izumo sperm-egg fusion protein 1, complete cds, transcript variant 2.
LC426750 - Rattus norvegicus Wistar Izumo1 mRNA for Izumo sperm-egg fusion protein, complete cds1, transcript variant 2.
Z29958 - G.domesticus (Hubbard White Mountain) mRNA for ubiquitin-ribosomal protein fusin protein.
X13493 - Chicken mRNA for ubiquitin-fusion protein.
BT074596 - Osmerus mordax clone omor-rgc-513-117 Lipoma HMGIC fusion partner homolog precursor putative mRNA, complete cds.
BT043912 - Salmo salar clone HM5_2544 ubiquitin A-52 residue ribosomal protein fusion product 1like 1 mRNA, complete cds.
BT043771 - Salmo salar clone HM6_1209 ubiquitin A-52 residue ribosomal protein fusion product 1-like mRNA, complete cds.
BC047167 - Danio rerio trk-fused gene, mRNA (cDNA clone MGC:55342 IMAGE:2601209), complete cds.
BC080473 - Xenopus tropicalis trk-fused gene, mRNA (cDNA clone MGC:89763 IMAGE:7027507), complete cds.
BC044319 - Xenopus laevis fusion, derived from t(12;16) malignant liposarcoma (human), mRNA (cDNA clone MGC:52724 IMAGE:4683823), complete cds.
AY600859 - Gallus gallus FUS/TLS mRNA, complete cds.
AY312055 - Danio rerio TEL/JAK2 fusion protein mRNA, complete cds.
KF891385 - Pygocentrus nattereri ubiquitin A-52 residue ribosomal protein fusion product mRNA, partial cds.
JX053363 - Callorhinchus milii clone P09E02.Testis.t065 mRNA sequence.
JX212368 - Callorhinchus milii clone P03J09.Testis.t065 ubiquitin fusion degradation protein 1-like protein mRNA, complete cds.
JX052986 - Callorhinchus milii clone P28C12.Kidney.k16 mRNA sequence.
JN859075 - Clarias gariepinus fushi tarazu factor 1 (FTZ-F1) mRNA, complete cds.
JX999939 - Paralichthys olivaceus fushi tarazu factor 1 mRNA, complete cds.
AY879313 - Oncorhynchus mykiss fushi tarazu factor 1 (FTZ-F1) mRNA, complete cds, alternatively spliced.
AY879314 - Oncorhynchus mykiss fushi tarazu factor 1 (FTZ-F1) mRNA, complete cds, alternatively spliced.
JF742993 - Oreochromis niloticus strain GIFT fushi tarazu factor-1 (FTZ-F1) mRNA, complete cds.
GU588175 - Ictalurus furcatus clone CBZF1175 lipoma hmgic fusion partner-like protein (LHFP) mRNA, complete cds.
GU589226 - Ictalurus punctatus clone CBZB11595 lipoma hmgic fusion partner-like protein (LHFP) mRNA, complete cds.
AY014863 - Clarias gariepinus fushi-tarazu factor 1-B (FTZ-F1) mRNA, complete cds, alternatively spliced.
KU312054 - Clarias batrachus fushi-tarazu factor 1-B (FTZ-F1) mRNA, complete cds.
AY014862 - Clarias gariepinus fushi tarazu factor 1-A (FTZ-F1) mRNA, complete cds, alternatively spliced.
AM259605 - Salmo salar partial mRNA for ubiquitin/ribosomal fusion protein homologue (ufph), clone FOR20.
EF446162 - Danio rerio vesicle fusion protein mRNA, complete cds.
CR760509 - Xenopus tropicalis finished cDNA, clone TEgg032d16.
AF533514 - Xenopus laevis FUSE binding protein-like protein mRNA, complete cds.
AF468978 - Salvelinus alpinus fushi tarazu factor 1 alpha mRNA, partial cds.
AF468977 - Salvelinus alpinus fushi tarazu factor 1 beta mRNA, partial cds.
AF288210 - Xenopus laevis TRK-fused protein TFG mRNA, complete cds.
M18041 - Avian transforming proviral retrovirus NK24 v-fos gene, partial cds.

GeneReviews

Emery-Dreifuss Muscular Dystrophy at chrX:136147465-136211359 - (FHL1)
Hereditary Diffuse Gastric Cancer at chr16:68737292-68835541 - (CDH1)
Emery-Dreifuss Muscular Dystrophy at chrX:154379197-154381523 - (EMD)
Emery-Dreifuss Muscular Dystrophy at chr1:156082578-156137865 - (LMNA)